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Abstract 
While DNA is most familiar in its double-stranded form as a storehouse of genetic 
information, its chemical similarities to naturally occurring ribozymes suggest that it can 
act as a catalyst. Single-stranded DNA molecules that have the ability to catalyze various 
bioorganic reactions are called deoxyribozymes. Deoxyribozymes do not occur naturally 
and are identified using a combinatorial chemistry technique called in vitro selection.  
Since the discovery of the first artificial deoxyribozyme that catalyzes cleavage of 
phosphodiester bonds in RNA molecules, a number of deoxyribozymes have been 
identified that catalyze different bioorganic reactions, including RNA ligation, DNA 
phosphorylation, DNA deglycosylation, etc. Most of these reactions involve RNA or 
DNA substrates, where catalysis is facilitated by Watson-Crick base pairing between the 
substrate and the DNA catalyst. A major challenge in the field is to identify 
deoxyribozymes that can catalyze reactions involving non-nucleic acid substrates, such as 
proteins and sugars.  
Addressing this challenge, we investigated the ability of DNA to catalyze reactions 
between amino acids that have nucleophilic side chains, such as tyrosine, serine, and 
lysine with a 5′-triphosphate-RNA electrophile. Previous efforts from our lab revealed 
DNA-catalyzed tyrosine reactivity, whereas serine proved refractory to catalysis. In the 
research described in Chapter 3, we identified for the first time, novel DNA enzymes that 
catalyze chemical modification of serine side chains. These deoxyribozymes were 
identified in a structurally preorganized three-helix-junction (3HJ) architecture that 
places the peptide nucleophile close to the triphosphate-RNA electrophile. We showed 
that these deoxyribozymes can discriminate between Ser and Tyr when presented at the 
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same amino acid position and can also distinguish between multiple Ser side chains at 
different positions in the peptide. In studies performed in parallel, our results indicated 
that obtaining DNA-catalyzed Lys side chain reactivity is relatively difficult. Selection 
experiments with lysine substrate led to deoxyribozymes that catalyze reaction of a 
phosphoramidite functional group instead of the Lys side chain.  
To address the difficulties in obtaining deoxyribozymes for Lys side chain reactions, 
we explored the ability of DNA to catalyze the reaction of amines with a more reactive 
electrophile, 2′,3′-cyclic phosphate as described in Chapter 4. However, multiple 
selection efforts involving the 2′,3′-cyclic phosphate electrophile, deoxyribozymes that 
catalyze a side reaction involving the ribose 2′-hydroxyl emerged. This study highlights 
some of the limitations of deoxyribozymes and the challenges associated with identifying 
deoxyribozymes that catalyze reactions involving amine nucleophiles. 
We also sought to identify deoxyribozymes that can covalently tag phosphopeptides 
with RNA. These studies are described in Chapter 5. Such deoxyribozymes can be 
employed as reagents to isolate phosphopeptides from a mixture of peptides. We 
identified DNA enzymes that catalyze the nucleophilic attack of the phosphate group 
present in phosphotyrosine- and phosphoserine-containing peptides on 5′-triphosphate-
RNA. These deoxyribozymes showed greater than 200-fold selectivity for 
phosphorylated peptides over non-phosphorylated analogs. The catalytic efficiency of 
one of these deoxyribozyme was assayed with a wide range of peptide substrates that 
differ in the identity of amino acid flanking the phosphorylated tyrosine. This 
deoxyribozyme catalyzes the reaction of these peptide sequences with similar catalytic 
efficiency.  
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Finally, as described in Chapter 6, we investigated the ability of DNA to catalyze 
phosphorylation of tyrosine and serine hydroxyls, that may be employed as artificial 
kinases. Artificial kinases could modulate numerous metabolic processes where naturally 
occurring kinases play an important role. In our first effort to identify kinase 
deoxyribozymes, we employed 5′-thiotriphosphate-RNA or GTPS as a phosphate donor. 
However, these selection experiments were unsuccessful, and we later identified that this 
was due to the instability of the thiotriphosphate moiety under the selection conditions. 
We then developed a novel selection approach that eliminated the use of 
thiotriphosphates. In this approach, capture deoxyribozymes that can attach an RNA 
molecule to phosphorylated peptides were employed to identify kinase deoxyribozymes. 
In these experiments the observed activity was found to depend on the covalent 
connection between the substrate and the DNA pool.  
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Chapter 1: Introduction to Nucleic Acids: Natural and Artificial 
1.1 Nucleic Acids in Nature 
Nucleic acids are biomolecules that perform processes fundamental to life, that of 
storage and transmission of genetic information. Nucleic acids are known in nature in the 
forms of DNA and RNA and have recently been observed to participate in several 
cellular processes in addition to their well-established roles in protein synthesis. This 
section briefly reviews some of the roles these biomolecules play in nature. 
1.1.1 DNA 
Deoxyribonucleic acid (DNA), a polymer made of deoxyribonucleotide units, 
constitutes the genetic material of most organisms. The monomeric units in this 
biopolymer contain a deoxyribose sugar, a base and a phosphate moiety (Fig. 1.1a). 
Figure 1.1. (a) Monomeric unit of DNA. (b) The four bases in DNA. 
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Naturally occurring DNA molecules contain four different bases: adenine (A), thymine 
(T), guanine (G) and cytosine (C) (Fig. 1.1b).  
In 1953, James Watson and Francis Crick first postulated that naturally occurring 
DNA exists as a double helix.
1
 These studies, based on X-ray crystallography, revealed 
that two antiparallel strands of DNA wind around the same axis in a right-handed helix, 
with the bases aligned perpendicular to the helical axis (Fig. 1.2). The phosphate groups 
line the exterior of the helix, exposed to the hydrophilic environment, and the bases are 
stacked in the interior of the double helix (Fig. 1.2). The diameter of the helix is 20 Å 
with the adjacent bases 3.4 Å apart and rotated 36° with respect to one another. The helix 
is stabilized by (i) hydrogen bonds between the bases, (ii) the π-π -stacking interactions 
between the bases. A forms two hydrogen bonds with T, and G forms three hydrogen 
Figure 1.2. Left: The structure of B-DNA. Right: Watson-Crick base pairing in GC and 
AT base pairs.     
 3 
bonds with C between the two DNA strands (Fig 1.2). This hydrogen-bonding pattern is 
referred to as Watson-Crick base pairing and the bases forming pairs are termed 
“complementary bases”. The Watson-Crick base pairing defines the secondary structure 
of nucleic acids.  
The two strands of DNA are called complementary strands. The end that has a free 5'-
hydroxyl at its ribose sugar is called the 5'-end, while the other end, which has a free 3'-
hydroxyl, is called the 3'-end of the strand. Complementary strands have opposite 
directionality, i.e. if one strand runs in the 5'3' direction, then the complementary 
strand runs in the 3'5' direction. In general, the sequence of nucleic acids is written in 
the 5'3' direction. 
Information about the DNA structure not only provided a view of how the DNA 
molecule maintains information, but also about how it replicates itself. These findings 
were thus critical in our current understanding of DNA function. 
1.1.2 Messenger RNA 
DNA is confined to the nucleus in eukaryotic cells. However, protein synthesis occurs 
in the cytoplasm. RNA, the second major class of nucleic acids, connects the genetic 
information stored in DNA to protein synthesis. 
Ribonucleic acid (RNA) is known mainly for its critical roles in protein synthesis. 
Similar to DNA, RNA is also a polymer made up of nucleotides, but has two major 
differences from DNA: (i) the 5-membered sugar in RNA is ribose while it is 2'-
deoxyribose in DNA, and (ii) RNA has uracil bases instead of thymine bases in DNA. 
There are many different kinds of RNA, including messenger RNA (mRNA), ribosomal 
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RNA (rRNA) and transfer RNA (tRNA). In this section, the function of mRNA will be 
discussed briefly.  
In eukaryotes, mRNA is synthesized in the nucleus by a process called transcription. 
This process employs DNA as a template and RNA polymerases for catalysis. During 
transcription, RNA polymerase recognizes the transcription initiation domain on the 
DNA, unzips the double-stranded DNA, and starts adding bases complementary to the 
DNA strand to form the RNA polymer.
2-5
 Transcription proceeds in the 5'3' direction, 
and the DNA strand is read in the 3'5' direction. The mRNA thus synthesized is called 
the pre-mRNA and is further processed before it is transported into the cytoplasm. The 
pre-mRNA is subjected to three kinds of processing: 5'-cap addition, polyadenylation, 
and splicing. In 5'-cap addition, a 7-methylguanosine cap is added at the 5'-end of RNA 
shortly after transcription initiation.
6
 This cap is important for recognition of RNA by the 
ribosome and also protects RNA from degradation by nucleases. In the process of 
polyadenylation, a poly-A tail is added at the 3'-end of mRNA.
7
 In eukaryotes, 
polyadenylation helps in transcriptional termination and also protects RNA from 
degradation by exonucleases. RNA splicing is the process by which non-coding regions 
of mRNA, which are called introns, are excised.
8-11
 The coding regions of mRNA are 
called exons. Splicing is generally catalyzed by an RNA-protein complex called the 
spliceosome. Splicing is also thought to increase diversity in gene expression. The same 
pre-mRNA can be spliced in different ways to give different mature mRNAs, thereby 
yielding different proteins. This phenomenon is called alternative splicing.  
The processed mature mRNA is then transported to the cytoplasm. This mRNA 
carries the genetic information encoded in the DNA, partially altered by splicing. mRNA 
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is read by the ribosome, a nucleoprotein complex that catalyzes protein synthesis in a 
process called translation.
12-15
  
1.1.3 Ribozymes 
In the early 1980s, the belief that RNA is a passive carrier of genetic information 
changed when catalytic RNA molecules were discovered. These RNA molecules were 
named riboyzmes.
10,16 
This discovery was a landmark; until that time, proteins were the 
only known biological catalysts. 
Thomas Cech and Sidney Altman independently discovered RNA molecules that 
catalyze different biological reactions. Thomas Cech’s lab was studying the splicing of 
ribosomal RNA in Tetrahymena thermophila. During these investigations, they could not 
identify any protein (enzyme) that catalyzes this splicing reaction, i.e. the excision and re-
ligation of RNA. In addition, the reaction occurred in absence of any cell extract, which 
led them to propose that the RNA molecule catalyzes its own excision and re-ligation.
10
  
Around the same time, Sidney Altman’s lab was studying the conversion of precursor 
tRNA to active tRNA.
17
 This reaction is catalyzed by RNase P, an enzyme that has both 
the protein and RNA component.
18,19
 Their lab proved that the RNA part of the enzyme 
catalyzes this reaction. Since then, many other natural and artificial RNA molecules have 
been isolated that are catalysts.
20
 
Recently, the high-resolution crystal structures of the ribosome revealed that its core 
catalytic component is made of RNA.
21-24
 These examples of catalytic RNA in nature 
clearly indicate that nucleic acids have both the chemical and structural complexity 
necessary to support catalysis.  
 6 
1.1.4 RNA interference 
RNA interference (RNAi), a gene silencing mechanism that was first discovered in 
Caenorhabditis elegans in 1998, has emerged as a powerful tool to control gene 
expression at the transcriptome level in a wide range of eukaryotic organisms.
25
 Three 
kinds of small RNA that participate in RNAi are: short interfering RNA (siRNA), repeat-
associated short interfering RNA (rasiRNA), and microRNA (miRNA).
26
  
The RNAi machinery is triggered by double-stranded RNA (dsRNA).
27
 RNA is 
generally found in the single-stranded form in nature, but may also exist as dsRNA, 
which is synthesized by either RNA-templated RNA polymerases or by hybridization of 
single-stranded RNA with complementary transcripts. These dsRNAs are processed into 
siRNAs or rasiRNAs. Endogenous RNA molecules that contain complementary base 
pairs and form dsRNA hairpin structures are processed into miRNAs. In addition, dsRNA 
can be artificially introduced into cells to inactivate corresponding genes.
28
  
Long dsRNAs in the cells are first recognized by RNase-III-type endonucleases 
called Dicer and Drosha.
29,30
 These proteins contain a dsRNA binding domain in addition 
to the RNase III catalytic domain and specifically cleave long dsRNAs into short ~21 
nucleotides dsRNAs that contain 2-nucleotide 3'-overhangs. These short RNAs are called 
siRNAs. siRNA can form a ribonucleoprotein complex called RNA-induced silencing 
complex (RISC).
31-33
 This complex contains another RNase called Slicer. siRNAs are 
first unwound by RISC and the resulting single-stranded RNA strand in RISC is directed 
towards the complementary target mRNA in a sequence- specific manner. This double-
stranded target mRNA-siRNA complex is cleaved in the middle of the duplex by Slicer. 
The cleaved mRNA is recognized as aberrant and degraded by nonspecific RNases. Thus, 
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siRNA serves as a translational suppressor by directing the cleavage of target mRNA. 
miRNA inhibits translation using a similar mechanism. 
1.1.5 Riboswitches 
Several small-molecule cellular metabolites are known to bind selectively to mRNA, 
changing its structural conformation and thus modulating gene expression. These 
sequences of mRNA are called riboswitches. The first riboswitch was identified in 
prokaryotes in 2002.
34
 Since then, other riboswitches have also been discovered in fungi 
and plants.
35
 Riboswitches are generally found in the 5'-untranslated region of mRNA 
and control gene expression by binding to small-molecule metabolites. Riboswitches are 
composed of two domains: an aptamer domain and an expression platform (Fig. 1.3). 
Aptamer domains are evolutionarily conserved regions of the transcriptome that 
selectively bind to cellular metabolites. The expression platform lies directly downstream 
of the aptamer domain and its secondary and tertiary structure directly influences gene 
expression.
36
 Part of the aptamer domain may overlap with the expression platform. 
Binding of a small molecule to the aptamer domain changes its structural conformation, 
which in turn changes the structure of the expression platform, leading to change in gene 
Figure 1.3. A simple model of a riboswitch that functions by inhibiting translation of mRNA 
in the presence of excess cellular metabolite. Binding of a cellular metabolite to the 
aptamer domain changes the structure of the expression platform, thus changing the 
accessibility of the ribosome binding site and inhibiting RNA translation.   
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expression. Such a mechanism to control gene expression is prevalent in bacteria and is 
can be used as a negative or positive feedback to control the concentration of cellular 
metabolites. Notably, this mechanism of regulation of transcription and translation 
involving only RNA survived evolutionary processes even when strong selective 
competition from proteins was present. 
The sections above highlight the diverse roles of nucleic acids in nature, ranging from 
gene expression to catalysis, gene silencing and substrate binding. The question that 
arises now is whether we can identify functional nucleic acids that are not known in 
nature. The next section will discuss some of the requirements for identification of such 
“artificial” functional nucleic acids. In addition, some of the advantages of working with 
nucleic acids over other biomolecules will also be discussed.   
1.2 Discovery of Functional Molecules 
Chemists and biochemists have discovered a plethora of functional molecules over 
decades, ranging from pharmaceutically important compounds to organometallic 
compounds that catalyze reactions with high selectivity and specificity.  Nature has 
generated an even more complex array of functional molecules with evolution. This 
section compares two fundamentally different approaches to isolate functional molecules, 
including the limitations and advantages of these approaches.  
1.2.1 Chemist’s vs. Nature’s approach 
Over decades of scientific research, chemists have discovered a large number of 
functional compounds, some of which have been discovered serendipitously, while others 
have been identified by high-throughput screening
37
 or rational design.
38
 In all of these 
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cases, the functional molecules were discovered by individually analyzing small-
molecule compounds. For example, at best high-throughput screening could assay 10
6
-
10
7
 compounds for their activity. In contrast, nature “discovers” functionally important 
compounds using a larger library size of putative functional molecules. For example, the 
library size for generation of antibodies is ~10
8
.
39
 Furthermore, this is done in a single 
container which could be a cell or an organism. This approach to design functional 
molecules can be achieved because nature can generate such large libraries of 
compounds, and it has evolved methods for selective amplification, i.e., methods for 
separating functional compounds from non-functional ones and amplifying them, thus 
propagating functional molecules. If it is desired to adopt nature’s approach in the 
laboratory, one should be able to generate a large library of compounds and also develop 
methods for selective amplification. In summary, three requirements need to be fulfilled: 
a) Generation of a large library of molecules.  
b) A method of separation of functional molecules from non-functional ones. 
c) A method of amplification. 
Nucleic acids satisfy all the above requirements for nature-inspired generation of 
functional molecules.  
1.2.2 Nucleic acids and a nature-inspired selection approach 
Nucleic acids fulfill the basic requirements for application of a selection approach 
inspired by nature, in the following way, 
a) Generation of a large library of nucleic acid molecules: Libraries of nucleic acids can 
easily be generated using the solid-phase synthesis method. The details of this method 
will be discussed in Chapter 2. The method allows synthesis of 10
14
-10
16
 different 
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sequences of DNA. All of these sequences are obtained in a single pot and not 
synthesized separately.        
b) Separation method- polyacrylamide gel electrophoresis (PAGE): PAGE has been 
used extensively for separating nucleic acid molecules based on mass and charge. 
Since the phosphate backbone of nucleic acid molecules is negatively charged, the 
molecules can move under the influence of an electric field. Polyacrylamide gels 
provide a medium in which nucleic acid molecules can migrate, and their mobility 
depends on the total electrical charge and the mass of the migrating molecules. This 
technique can provide the basis for separating functional nucleic acid molecules from 
non-functional ones.
40
 
c) Amplification method, Polymerase chain reaction (PCR): The PCR technique41 
revolutionized the field of molecular biology by providing a tool to amplify DNA. 
PCR uses thermostable DNA polymerases, most commonly, Taq polymerase. Taq 
polymerase was first isolated from a thermophilic bacterium called Thermus 
aquaticus.
42
 It has optimal activity between 72-80°C, and is stable even at 
temperatures as high as 95°C. These properties of Taq polymerase makes it 
operationally suitable for the process of PCR. Details on how PCR amplifies DNA 
are discussed in Chapter 2.    
Both the chemical properties of nucleic acids and the ease with which functional 
nucleic acids can be identified suggested that they can be isolated in the laboratory using 
selection-based approaches. In 1990, the first artificial single-stranded RNA-based 
ligands called aptamers were discovered using in vitro selection.
43
 Subsequently, DNA 
aptamers were discovered using a similar methodology.
44
 These discoveries laid the 
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foundation for identification of the first artificial single-stranded DNA catalysts called 
deoxyribozymes in 1994. The next two sections will give a brief overview of nucleic acid 
aptamers and deoxyribozymes.  
1.3 Nucleic Acid Aptamers 
Nucleic acid aptamers are single-stranded DNA or RNA molecules that selectively 
bind to their target. These nucleic acid molecules can fold into well-defined complex 
molecular structures suitable for binding to ligands. Aptamers can have substrate 
affinities and specificities comparable to protein-based antibodies and can bind to a 
variety of substrates, ranging from small molecules to proteins and even to the surface of 
individual cells.  
Aptamers are isolated in the laboratory using an in vitro selection technique called 
“systematic evolution of ligands by exponential enrichment” (SELEX).45-47 In a typical 
SELEX experiment, a random library of oligonucleotides is first generated using the 
standard solid-phase synthesis procedure explained in Chapter 2 of this thesis. This 
library of oligonucleotides contains DNA molecules that have a random region, typically 
between 20-100 nucleotides. This random region is flanked by two constant 
oligonucleotide sequences required for enzymatic manipulations. The library of 
oligonucleotides is called the DNA pool. SELEX experiments generally start with 0.1 to 
1 nanomole of DNA molecules. Thus the DNA pool contains 10
13
-10
14
 different 
molecules. Fig. 1.4 illustrates the procedure followed for a typical in vitro DNA aptamer 
selection.
45
 The DNA pool is first incubated with the substrate bound to a solid support. 
DNA sequences that do not bind to the substrate are removed by washing. This is 
followed by the elution step, where DNA sequences that are bound to the solid support 
 12 
via substrate, are eluted using free substrate. The eluted DNA molecules thus obtained 
are then amplified by PCR and serve as the starting point for the next round of selection. 
This procedure is repeated and with each iteration the DNA pool is enriched with 
sequences that bind tightly to the substrate. RNA aptamers are identified using a similar 
procedure, but involves additional steps of reverse-transcription to DNA for PCR 
amplification followed by transcription to regenerate RNA.  
The field of aptamers has come a long way since the time they were initially 
discovered in 1990. Numerous DNA and RNA-based aptamers have been isolated which 
are important in therapy as well as diagnosis of several diseases,
48-50
 including aptamers 
that have shown promise in treatment of life-threatening diseases such as HIV infection 
and cancer.
51
  
Figure 1.4. Procedure for a typical DNA aptamer selection. (Adapted from Ref. 45) 
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1.4 Deoxyribozymes  
1.4.1 Introduction 
Single-stranded DNA molecules that have the ability to catalyze bioorganic reactions 
are called deoxyribozymes. Deoxyribozymes are also referred to as DNA catalysts, DNA 
enzymes, or DNAzymes. The discovery of ribozymes in nature suggested that nucleic 
acids can catalyze complex bioorganic reactions. This discovery generated interest in the 
novel catalytic role played by nucleic acids and marked a starting point for the 
development of artificial nucleic acid-based catalysts. With the advent of PCR, it became 
possible to generate multiple copies of few nucleic acid sequences. The development of 
solid-phase nucleic acid synthesis method enabled generation of libraries of 10
13
-10
14
 
different DNA sequences. These two technological advancements propelled the 
development of artificial DNA catalysts.   
The first artificial DNA catalyst was identified by Joyce and Breaker in 1994.
52
 This 
deoxyribozyme cleaves a single ribonucleotide linkage embedded within an otherwise 
all-DNA substrate. Subsequently, several RNA-cleaving deoxyribozymes were 
discovered.
53-55
 These deoxyribozymes catalyze the nucleophilic attack of 2'-hydroxyl of 
the ribose sugar on an adjacent phosphodiester bond leading to formation of a 2',3'-cyclic 
Figure 1.5. RNA cleavage catalyzed by 10-23 deoxyribozyme. 
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phosphate (Fig. 1.5). Since then, a number of other deoxyribozymes have been isolated 
that catalyze different bioorganic reactions including RNA ligation,
56-62
 DNA ligation,
63
 
DNA phosphorylation,
64
 DNA deglycosylation,
65
 oxidative cleavage of DNA,
66
 DNA 
hydrolysis,
67
 and Diels-Alder reaction.
68
  
Deoxyribozymes are identified using an in vitro selection procedure. This procedure 
is similar to the SELEX process for identification of aptamers and is discussed in detail in 
Chapter 2. Using the in vitro selection procedure, catalytic DNA molecules are isolated 
from a completely random library of DNA sequences, and the procedure does not require 
any prior structural information about the catalytic DNA. It is interesting to note that to 
date no three-dimensional structural information (X-ray or NMR) is available for any 
deoxyribozyme, although a number of deoxyribozymes have been discovered. The 
methodology of isolating catalytic DNA is in contrast to directed evolution techniques 
used for identification of artificial protein-based catalysts, which require information of 
the three-dimensional structure of the active site of the protein.  
1.4.2 Applications of deoxyribozymes  
As with any artificial catalyst, there is both fundamental as well as practical interest 
in developing deoxyribozymes. A number of RNA-cleaving DNA catalysts, such as 8-17 
and 10-23 deoxyribozymes, are now used as biochemical reagents to cleave specific 
sequences of RNA at a particular site.
62,69,70
 These deoxyribozymes are also utilized to 
generate RNA molecules with 2',3'-cyclic phosphate at their 3'-terminus.  
Recently, it was shown that DNA catalysts can also be used to label a specific 
sequence of RNA at a particular site in the RNA molecule.
71
 The 10DM24 
deoxyribozyme
72
 that catalyzes the formation of 2',5'-branched RNA was employed to 
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selectively attach a fluorescent or a biotin tag at an internal 2'-hydroxyl in the RNA 
molecule. In this study, specific sites in the P4-P6 domain of Group I intron were labeled 
with a fluorescent tag and the folding of this domain was studied using fluorescence 
resonance energy transfer (FRET).   
Integrating aptamers into deoxyribozymes has resulted in a new class of molecules 
called aptazymes.
73-77
 Aptazymes have a catalytic domain and an aptamer domain. 
Binding of a ligand to the aptamer domain modulates the catalytic activity of the 
deoxyribozyme (catalytic domain), and this modulation can be exploited to design 
sensors for the ligand. In one such example of aptazymes, an ATP aptamer was 
incorporated into a RNA-ligating deoxyribozyme. The activity of this deoxyribozyme 
changes in the presence of ATP.
78
   
1.5 Research Focus of This Thesis  
The focus of the research work reported in this thesis was on the identification of 
novel deoxyribozymes that catalyze reactions involving peptide substrates. Most known 
DNA-catalyzed reactions involve RNA or DNA substrates, where the catalysis is 
facilitated by Watson-Crick base pairing between the substrate and the DNA catalyst. A 
major challenge in the field is to include non-nucleic acid substrates such as proteins and 
sugars into the repertoire of DNA-catalyzed reactions. This will allow development of 
deoxyribozymes for different bioorganic reactions for which naturally-occurring catalysts 
do not exist or could not be utilized due to their limited substrate scope. 
Deoxyribozymes were sought for three different reactions: nucleopeptide linkage 
formation, covalent tagging of phosphopeptides, and phosphorylation reactions. Chapter 
2 discusses various methods that were employed during the course of this thesis research, 
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including the in vitro selection procedure to identify deoxyribozymes and synthetic routes 
adopted to prepare various nucleic acid-peptide conjugates that were used as substrates 
for in vitro selections. Chapter 3 focuses on the discovery of deoxyribozymes that 
catalyze chemical modification of serine side chains. Chapter 4 discusses attempts to 
identify deoxyribozymes that can covalently modify lysine side chains. Chapter 5 focuses 
on development of DNA catalysts that can covalently tag phosphopeptides. Finally, 
Chapter 6 discusses attempts to identify tyrosine and serine kinase deoxyribozymes.   
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Chapter 2: Methods  
2.1 In Vitro Selection Procedure  
Deoxyribozymes are identified using a procedure known as in vitro selection.
1
 In 
vitro selection is a combinatorial chemistry technique, inspired by natural selection, to 
identify enzymes with novel catalytic properties. Various steps involved in this technique 
are discussed in this section.  
To illustrate the general procedure, an example of in vitro selection of 
deoxyribozymes that catalyze ligation of two RNA molecules
2
 is discussed here. Fig. 2.1 
shows various steps involved in this procedure. A completely unbiased ensemble of DNA 
sequences (also called a DNA pool) is first generated via solid-phase synthesis of DNA. 
Each DNA molecule has fixed regions (brown), required for primer binding for PCR 
Figure 2.1. General scheme for in vitro selection of RNA-ligating deoxyribozymes. 
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amplification, and a completely random region (green), also called the enzyme region. 
This ensemble of DNA molecules is then ligated to the substrates. This is followed by the 
reaction for which enzymes are being selected (the selection reaction), and the products 
bound to the catalytically active DNA are separated from the starting substrate bound to 
the DNA pool. The methodology of separation depends upon the reaction being 
catalyzed. For example, ligation of two RNA molecules yields a new RNA molecule with 
larger mass that can be separated on the basis of its slower electrophoretic mobility using 
PAGE (Fig. 2.1). The DNA molecules attached to the products are then amplified by 
PCR, and the steps of ligation to the starting material and selection reaction are repeated 
iteratively, thereby enriching catalytically active sequences in every round. Once the 
catalytic activity of the pool of DNA sequences reaches a saturation value, individual 
deoxyribozyme sequences are identified by cloning. The following steps are involved in 
the in vitro selection procedure.  
1) Synthesis of the initial DNA pool 
2) Ligation of DNA pool molecules to the substrate 
3) Selection step 
4) PCR to amplify catalytic sequences 
5) Cloning of DNA pool  
The experimental details of each of these steps are discussed in this section. 
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2.1.1 Synthesis of the initial DNA pool 
The initial DNA pool is prepared by the solid-phase synthesis method. The solid-
phase synthesis of nucleic acids is a fully automated process and is based on 
phosphoramidite chemistry.
3
  A general scheme for solid-phase synthesis of DNA is 
shown in Scheme 2.1. Nucleic acid strands are synthesized in the 3'→5' direction on a 
solid support. Controlled-pore glass (CPG) is the most common solid support used for 
synthesis of oligonucleotides. CPG is available in different pore sizes of 500, 1000, 1500, 
2000, and 3000 Å and allows for preparation of about 50, 80, 100, 150, and 200-mer 
oligonucleotides, respectively. Generally, commercial solid supports have the 3'- 
nucleotide bound via its 3'-hydroxyl to the solid support (Scheme 2.1).   
The first step of solid-phase synthesis involves deprotection of the 5'-hydroxyl using 
trichloroacetic acid (TCA). This step is called the deblocking step. The free 5'-hydroxyl is 
Scheme 2.1. Solid-phase synthesis procedure for generation of DNA molecules. 
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then coupled to the next nucleotide by reacting with the phosphoramidite of this 
nucleotide. This step is called the coupling step. Subsequently, phosphorus is oxidized 
from the +3 to +5 state using I2/pyridine/H2O. This step is called the oxidation step.  The 
small fraction of uncoupled 5'-hydroxyl group is blocked by using acetic anhydride 
solution, so that it cannot participate in further couplings. This step is called the capping 
step. The DMT-protected 5'-end of the newly added nucleotide is deprotected in the 
deblocking step and steps of coupling, oxidation, capping, and deblocking are iterated to 
obtain a particular sequence of DNA. After completion of the synthesis, the DNA strand 
is released from the solid support by incubation with 30% aqueous NH4OH solution for 2 
h at 25 
o
C.  
As with any solid-phase synthesis method, oligonucleotide synthesis involves use of 
orthogonal protecting groups. During the synthesis, acid (TCA) is used to deprotect the 
5'-hydroxyl. Thus, nucleobases with base-labile protecting groups are used during 
synthesis of oligonucleotides. These protecting groups are required to prevent any side 
reaction on the nucleobases during the synthesis. The nucleobases are deprotected after 
completion of synthesis by incubation in 30% aqueous NH4OH solution for 12 h at 55 
o
C. 
 The initial DNA pool for the selection experiments contains a mixture of DNA 
sequences that have (i) the two fixed sequence regions called the primer-binding regions 
that are required for PCR amplification and (ii) one random region of fixed length (N40 in 
Fig. 2.1) that has completely random nucleotide composition. To synthesize the DNA 
pool, a mixture of A, T, G and C phosphoramidites is used during solid-phase synthesis 
of the random region. The mole ratio of these phosphoramidites is adjusted to account for 
their unequal coupling efficiencies. After the synthesis, these DNA molecules are cleaved 
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from the CPG and purified by PAGE. This pool of DNA molecules is then coupled to the 
substrate in the next step.  
2.1.2 Ligation of DNA pool molecules to the substrate 
To enable capturing catalytic DNA sequences after the selection step, the substrate is 
covalently attached to DNA sequences in the pool. In this work, either RNA or DNA 
ligase was used to accomplish this covalent attachment. Both of these enzymes are 
commercially available. 
a) Ligation using RNA ligase: RNA ligase catalyzes the ligation of a 5'-phosphorylated 
nucleic acid to a 3'-hydroxyl of RNA through the formation of a phosphodiester 
bond.
4-9
 This reaction is accompanied by hydrolysis of ATP to AMP and PPi. RNA 
ligase was employed to ligate the 5'-end of DNA pool to the 3'-end of a RNA 
substrate. The phosphorylated DNA pool was incubated with two-fold excess of RNA 
substrate at 37 
o
C for 12-14 h in the presence of T4 RNA ligase. The ligated product 
was separated from the unligated pool by 
PAGE (Fig. 2.2). RNA ligase catalyzes 
ligation of the 5'-end of an RNA or DNA 
molecule to the 3'-end of a oligonucleotide 
that has at least three ribonucleotides at its 
3'-terminus. RNA ligase cannot catalyze 
ligation of two DNA molecules. 
b) Ligation using DNA ligase: DNA ligase catalyzes the ligation of two DNA strands. In 
nature, DNA ligase is used by cells to repair double-stranded DNA breaks in the 
genome.
10
 DNA ligase was employed to ligate the 3'-end of DNA pool molecules to 
Figure 2.2. Ligation of DNA pool to RNA 
substrate using T4 RNA ligase. 
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the 5'-end of a DNA substrate. Ligation using DNA ligase also involves another DNA 
molecule called the “splint” (Fig. 2.3). The splint DNA has two regions, one of which 
is complementary to the DNA pool and the other that is complementary to the DNA 
substrate. The Watson-Crick base pairing between the splint, DNA pool and the DNA 
substrate is required for the ligation reaction.
11
 
The DNA pool was incubated with 1.5-fold excess of splint and two-fold excess 
of phosphorylated DNA substrate at 37 
o
C for 12-14 h in presence of T4 DNA ligase. 
The ligated product was separated from the unreacted DNA pool by PAGE. Ligation 
reactions with DNA pools generated using solid phase synthesis showed high yields 
but those with PCR-generated DNA pools showed poor yields. The cause for low 
yields was identified to be the heterogeneity at the 3'-end of the DNA pool generated 
using Taq polymerase. Taq polymerase usually adds an extra A at the 3'-end. To 
solve this problem, a splint with an extra T at the ligation junction was used to ligate 
the PCR-generated DNA pool to the DNA substrate.    
Figure 2.3. Ligation of DNA pool to the substrate using T4 DNA ligase. 
 30 
2.1.3 The selection step 
In the key selection step, DNA pool molecules ligated to one of the substrates were 
incubated with the second substrate. The selection reaction was performed in the 
presence of divalent metal ions, such as Mg
2+
 or Mn
2+
, under buffered conditions. The 
reaction volume was 20 L. The ligated DNA pool, along with the second substrate was 
first annealed by heating the sample at 95 
o
C for 3 min, then cooled on ice for 5 min and 
maintained at 37 
o
C for 2 min. Metals ions were added after annealing.  
When DNA catalysts for the desired reaction exist in the DNA pool, the reaction 
product ligated to the catalytic DNA is obtained. This is called the selection product. The 
selection product has different mass and charge when compared to unreacted starting 
material, hence has different electrophoretic mobility on PAGE than the latter. This 
difference in mobility was used as the basis for separation, and the selection product 
ligated to the enzyme that catalyzes the reaction was isolated.  
During initial rounds of selection, the catalytic DNA molecules form a very small 
fraction of the DNA pool, hence below the detection limit of the phosphorimager used for 
detection of radioactivity. The separated selection product bands are hence not visible on 
the gel, and are excised with the guidance of a selection standard that was run on PAGE 
along with the selection reaction. The selection standard was an oligonucleotide that has 
mass and charge similar to the selection product. Molecules from these bands were 
extracted and amplified by PCR in the next step. In this manner, with every round of 
selection, the DNA pool is enriched with catalytic sequences. 
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2.1.4 PCR to amplify catalytic sequences 
Catalytic DNA molecules obtained from the selection gel are exponentially multiplied 
using polymerase chain reaction (PCR).
12
 PCR is a technique used to generate multiple 
copies of DNA sequences from one or a few copies of DNA molecules. The DNA 
molecules that are amplified are called the template DNA. PCR uses a thermostable DNA 
polymerase called Taq polymerase and also requires two short DNA sequences called the 
PCR primers. One of the PCR primers is complementary to the 3'-end of template DNA, 
and the other primer binds to the 3'-end of the template DNA’s complement. The process 
of PCR generates both the template and its complementary strand.
13
  
Because both the DNA enzyme strand and its complement are obtained using PCR, 
different methods have been developed to physically separate these two strands.
14,15
  In 
one such method, the 5'-end of one of the PCR primer is linked to a long oligonucleotide 
via a non-amplifiable linker. The PCR products obtained using this primer have larger 
mass compared to the complementary strand and can be separated by PAGE.  
In each round of selection, two PCR reactions were performed: a 10-cycle PCR, 
followed by a 30- cycle PCR. The 10 cycle PCR was performed in 100 L; this reaction 
used 200 picomoles of the primer that yields DNA enzyme strand, 50 picomoles of the 
other primer which also contains a non-amplifiable tail and 20 nanomoles of each of four 
deoxynucleotide triphosphates (dNTPs). 1 L of the reaction mixture from the 10-cycle 
PCR is used as a template for a 30 cycle PCR. 30 cycle PCR is performed in 50 L; 100 
picomoles of the primer that yields DNA enzyme strand, 25 picomoles of the other 
primer and 10 nanomoles of each of four dNTP’s are used. In addition, trace amount of 
-32P-dCTP is added in 30 cycle PCR. 32P is a radioisotope of phosphorus and emits 
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high-energy -particles that can be detected using the phosphorimager. Addition of a 
radioactive tag in PCR products greatly increases the detection limit of the products. The 
two PCR products, the DNA enzyme strand and its complementary strand, that differ in 
molecular weight due to the DNA tail in complement strand, are separated by PAGE. The 
DNA enzyme strand is again ligated to the substrate followed by the selection reaction. 
Each round of selection constitutes three steps: a) PCR, b) ligation reaction, and c) 
selection reaction. In every round of selection the DNA pool is enriched with catalytic 
sequences, until the observed activity saturates. Finally, the DNA pool containing 
catalytic sequences is cloned.  
2.1.5 Cloning the DNA pool 
After the selection process a pool enriched with catalytic DNA molecules is obtained. 
These DNA molecules have same number of nucleotides (approximately same molecular 
weight) but may differ in their nucleotide composition. To identify individual sequences, 
cloning is performed.  
The 10 cycle PCR product of the selection round that needs to be cloned is used as a 
PCR template to generate double-stranded DNA for cloning. This double-stranded DNA 
product is purified on agarose gel and inserted into a vector that forms plasmids. Cells are 
then transformed with these plasmids. These cells are spread on cell culture media plates 
and the plate is incubated at 37 
o
C for 14-16 hrs. During this time cells multiply and 
colonies of cells form around individual cells. Cells are picked from these colonies and 
further grown in culture media. A standard TOPO cloning protocol (Invitrogen)
16
 was 
adopted whenever DNA pools were cloned during the thesis work.  
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Each cell contains plasmids corresponding to the one particular sequence. Hence, 
each colony corresponds to one particular DNA enzyme sequence. Thus, the cloning 
procedure ensures separation of individual DNA sequences from a pool of DNA 
sequences. The DNA from these cells is obtained and sequenced. These DNA sequences 
are then prepared by solid-phase DNA synthesis and their catalytic properties are further 
characterized.    
2.2 Synthesis of Nucleic Acid-Peptide Conjugates  
The focus of this thesis is to identify deoxyribozymes that can catalyze reactions 
involving peptide substrates. In order to achieve this goal, various nucleic acid-peptide 
conjugates were synthesized using solid-phase and solution-phase synthesis methods. The 
following sections will discuss these synthetic methodologies.  
2.2.1 Solid-phase synthesis of DNA-peptide-DNA conjugates 
Peptides embedded within a DNA strand were synthesized using solid-phase 
synthesis methods. Scheme 2.2 describes this procedure.  
A three-step approach was adopted to generate DNA-peptide-DNA conjugates.
17,18
 
(a) First, the 3′-portion of DNA was synthesized on a solid support using 
phosphoramidite chemistry (see Section 2.1.1). This synthesis was performed on an ABI 
394 DNA synthesizer. (b) Then, the DNA attached to the solid support is removed from 
the synthesizer and amino acids are manually coupled to this DNA strand. (c) Next, the 
5′- portion of the DNA-peptide conjugate is further extended using the DNA synthesizer. 
In the first step, a 200 nmole synthesis of the 3′-portion of DNA with 5′-terminal 5′-
amino-5′-deoxythymidine was performed on the solid support. The final coupling of the 
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series was performed using the 5′-amino-modified thymidine phosphoramidite from Glen 
Research in which the 5′-NH2 group is protected using the acid-labile monomethoxytrityl 
(MMT) group. The MMT group was deprotected using 3% TCA in CH2Cl2.  
Scheme 2.2. Solid-phase synthesis of DNA-peptide-DNA conjugates. 
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In the second step, the free 5′-NH2 was manually coupled to a MMT protected amino 
acid monomer. This was achieved using HATU/HOBt as coupling agent and N-
methylmorpholine (NMM) as the base in DMF. The reaction was performed with 0.1 
mmole of MMT-protected amino acid, 0.098 mmole of HATU, 0.1 mmole of HOBt and 
0.3 mmole of NMM dissolved in 500 μL of DMF and incubated with the DNA strand on 
solid support obtained from step 1 for 1 h, and then washed with 10 mL of CH3CN and 
10 mL of CH2Cl2. After the coupling step, the uncoupled amino group was capped using 
a mixture of acetic anhydride, pyridine, and 1-methylimidazole (5% each) in THF that 
was prepared by mixing 500 μL of Glen Research Cap Mix A (10% each of acetic 
anhydride and pyridine in THF) with 500 μL of Cap Mix B (10% 1-methylimidazole in 
THF). Capping was performed for 30 min. Subsequently, the sample was washed with 10 
mL of acetonitrile, and then with 10 mL of CH2Cl2. Deprotection of MMT was achieved 
with 3% TCA in CH2Cl2, unmasking the free α-amino group for the next coupling. This 
process was iterated for coupling the next amino acid.  
After all amino acids are added to the DNA chain, the peptide-DNA conjugate 
attached to the solid support is transferred back to the DNA synthesizer for synthesis of 
5′-end of the conjugate in the third step. The free α-amino group in the DNA-peptide 
conjugate is coupled to the first phosphoramidite after the peptide using standard DNA 
coupling conditions. This leads to formation of a phosphoramidate linkage, and thereafter 
other nucleotides are added that are linked by standard phosphodiester bonds. The final 
DNA-peptide-DNA product was removed from the solid support and fully deprotected 
with 29% aqueous ammonia at 55ºC for 12 h and purified by 20% denaturing PAGE. The 
products were quantified by UV absorbance (A260); yields were 10–20 nmol of each 
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DNA-peptide-DNA strand. Product identities were confirmed by MALDI-TOF mass 
spectrometry.  
2.2.2 Solution-phase synthesis of nucleic acid-peptide conjugates 
Two methods were employed for solution-phase synthesis of DNA-peptide 
conjugates: 
a) Reductive amination to conjugate N-terminus of peptide to dialdehyde at 3′-end of 
DNA. 
First, different peptide sequences were synthesized using standard Fmoc-based 
solid-phase synthesis. HATU was employed as a coupling agent for these syntheses. 
The N-terminus of these peptides was coupled to 3′-riboadenosine-terminated-DNA 
(3′-riboA-DNA) as described in Scheme 2.3. The 3′-rA-DNA was prepared using a 
standard solid-phase DNA synthesis procedure. The 2′,3′-diol of the ribose sugar at 
the 3′-end of DNA was oxidized using sodium periodate. NaIO4 is commonly used to 
oxidize vicinal diols to dialdehydes. This reaction was performed in 100 L by 
incubating 1-2 nmoles of 3′-riboadenosine terminated-DNA in 10 mM NaIO4 at pH 
7.5 (100 mM HEPES buffer). The reaction mixture was kept at 25 
o
C for 1 h. The 
oxidized product was precipitated by adding 10 L of 3M NaCl and 300 L of EtOH 
to remove excess NaIO4. The precipitated product was redissolved in H2O.  
Scheme 2.3. Conjugation of 3′-rA-DNA to N-terminus of the peptide. 
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 3′-dialdehyde DNA was then coupled to the N-terminus of the peptide using 
reductive amination. The reductive amination reaction was performed by incubating 
1-2 nmoles of 3′-oxidized DNA with 100-fold excess of peptide in presence of 50 
mM Ni
2+
 and 10 mM NaCNBH4 at pH 5.2 (100 mM NaOAc buffer). The reaction 
mixture was incubated at 37 
o
C for 12-14 h, and the DNA was ethanol-precipitated to 
remove salts. DNA coupled to the peptide was then separated from the uncoupled 
DNA using PAGE and its identity confirmed by MALDI-MS. The coupled product 
was isolated using 20% denaturing PAGE and its identity confirmed by MALDI-MS.  
b) Coupling between cysteine-containing peptide and thiol-containing-DNA.    
Cysteine-containing peptides were coupled to 5′- or 3′-thiol terminated DNA 
molecules (Scheme 2.4). 5′- or 3′-disuphide containing oligonucleotides (DNA-C3-
SS-C3-OH) were prepared using a standard solid-phase DNA synthesis procedure on 
a DNA synthesizer. These oligonucleotides were first reduced using dithiothreitol 
Scheme 2.4. Conjugation of thiol-DNA to cysteine containing peptide. 
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(DTT). 2-4 nmoles of DNA-C3-SS-C3-OH was incubated in 50 mM DTT at pH 7.5 
(50 mM HEPES) for 2 h at 37 
o
C. The reaction mixture was then ethanol-precipitated 
to remove excess DTT and dissolved in 45 L of H2O. The DNA-C3-SH thus 
obtained was pyridyl-activated using 2,2'-dipyridyl disulphide (DPDS). 5 L of 100 
mM DPDS in DMF was added to 45 L of DNA-C3-SH and incubated at 37 
o
C for 2 
h. The reaction mixture was again precipitated using ethanol and dissolved in 25 L 
of H2O. 5 L of 20 mM Cys-peptide (in formamide) and 20 L of 50 mM 
Triethylammonium acetate (TEAA) buffer (pH 7.0) was added to 25 L of DNA-C3-
SS-Py and incubated at 37 
o
C for 2 h. The conjugated product was separated by 
PAGE and its identity confirmed by MALDI-MS.   
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Chapter 3: DNA-Catalyzed Serine Side Chain Reactivity and 
Selectivity
a
 
3.1 Introduction 
In this project we investigated the ability of DNA to catalyze reactions involving 
amino acid side chains, such as tyrosine and serine side chains with a 5′-triphosphate-
RNA electrophile. These covalent linkages are important in many biological processes. 
For example, linkages between 5′-end of DNA or RNA to tyrosine are necessary for 
topoisomerase activity
1-4
 and are also found in picornaviruses such as the poliovirus.
5-7
  
Most known deoxyribozymes catalyze reactions involving oligonucleotide 
substrates.
8-13
 The Watson-Crick base pairing between the substrate and the DNA enzyme 
facilitates the reaction by bringing the substrate and the enzyme in close proximity. With 
the aim of including non-oligonucleotide substrates into the repertoire of DNA-catalyzed 
reactions, our laboratory has earlier isolated Tyr1 deoxyribozyme that catalyzes the 
nucleophilic attack of tyrosine phenolic hydroxyl on 5′-triphosphate-RNA, leading to 
formation of the nucleopeptide linkage.
14
 During the selection process that led to the 
identification of Tyr1, tyrosine was placed at the intersection of a three-helix junction 
(3HJ) formed from candidate deoxyribozyme sequences and two nucleic acid strands. 
One of these strands comprised DNA containing the embedded tyrosine, whereas the 
other strand was 5′-triphosphate-RNA (Fig. 3.1). The 3HJ architecture, inspired by the 
                                                 
a
 The material described in this chapter has in part been published and in part submitted for 
publication. 
(i) Sachdeva, A.; Silverman, S. K. DNA-catalyzed serine side chain reactivity and selectivity. 
Chem. Commun. 2010, 46, 2215-2217.  
(ii) Sachdeva, A.; Silverman, S. K. DNA-catalyzed reactivity of a phosphoramidate functional 
group and formation of an unusual pyrophosphoramidate linkage. 2011, submitted for 
publication. 
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discovery of 7S11 and related deoxyribozymes that catalyze formation of 2′,5′-branched 
RNA,
15-17
 spatially juxtaposes a nucleophile (e.g., tyrosine OH group) and electrophile 
(5′-triphosphate). This design allows probing the ability of DNA sequences to catalyze 
the desired chemical reaction without requiring that the DNA also bind a separate free 
substrate molecule. 
In parallel with selections for Tyr1, experiments were performed in which a single 
serine or lysine residue (rather than tyrosine) was placed at the 3HJ intersection (Fig. 
3.1).
14
 However, no active deoxyribozymes were found. In the case of serine, 
deoxyribozymes with only ~0.2% yield were identified; in the case of lysine, no 
reactivity at all was observed. 
In the work described in this chapter, the preorganization within the 3HJ 
conformation was relaxed by introducing a tripeptide at its intersection (Fig. 3.2). Our 
Figure 3.1. Deoxyribozyme architecture used to investigate DNA-catalyzed amino acid 
side chain reactivity. a) The three-helix-junction (3HJ) architecture brings together the 
amino acid side chain and the electrophilic 5′-triphosphate. b) The previously reported 
Tyr1 deoxyribozyme forms a tyrosine-RNA nucleopeptide linkage. 
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goal in these investigations was to find if such relaxation can facilitate DNA-catalyzed 
reactions involving serine and lysine side chains.  
3.2 Results and Discussion 
Four different selections were designed with tripeptide-containing substrates as 
shown in Fig. 3.2. A substrate containing only alanine served as the negative control. All 
of the DNA-peptide-DNA conjugates were synthesized using the procedure outlined in 
Chapter 2, Section 2.2.1. The general selection procedure and the steps involved are also 
described in Chapter 2. Briefly, at the outset of each round of the selection process, the 
5′-triphosphate-RNA was ligated via its 3′-terminus to the 5′-end of the deoxyribozyme 
pool strand. Any DNA sequence that successfully catalyses the reaction of the amino acid 
side chain in the tripeptide-containing substrate to the 5′-triphosphate-RNA (as shown in 
Fig. 3.2) becomes separable from even a substantial excess of catalytically inactive DNA 
sequences by polyacrylamide gel electrophoresis (PAGE) due to the added length of the 
tripeptide-containing strand. During the key selection step of each round, the incubation 
conditions were 50 mM HEPES, pH 7.5, 150 mM NaCl, 2 mM KCl, 20 mM MnCl2, and 
Figure 3.2. Deoxyribozyme architecture used in present investigations. Tripeptide, Ala-
Xaa-Ala (Xaa = Ser, Lys, Tyr, Ala, Ala is a negative control) was placed at the 3HJ 
intersection to pursue new DNA-catalyzed reactivity of serine and lysine side chains. 
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40 mM MgCl2 at 37 °C for 2 h. Both Mn
2+
 and Mg
2+
 were included because both divalent 
metal ions have supported various DNA-catalyzed reactions.
10,11,18
  
3.2.1 Progress of selection 
For these selections, 3′-phosphate was placed at the 3′-end of each tripeptide-
containing substrate, to block unwanted nucleophilic reactivity of the DNA 3′-hydroxyl 
group (Fig. 3.2). In selection round 4, detectable catalytic activity (>1%) was observed in 
each of four separate selection experiments with Ala-Xaa-Ala tripeptide-containing 
substrates, where Xaa = Tyr, Ser, Lys, or as a control lacking any nucleophilic side chain, 
Ala. Activity was observed both for intramolecular (in cis) reaction, in which the 
substrate was covalently ligated to the DNA pool, and intermolecular (in trans) reaction. 
The PAGE migration rate of each product formed in trans was compared with the 
migration rate of an appropriate synthetic standard (a branched DNA-RNA conjugate), 
whose migration rate should correspond closely to that expected upon nucleopeptide 
linkage formation.  
A branched PAGE standard was prepared using the previously known 9HR17 
deoxyribozyme, which forms a 2′,5′-branched nucleic acid product from DNA-rA-DNA 
and 5′-triphosphate-RNA substrates (Fig. 3.3).14 The 9HR17 product has similar 
Figure 3.3. 9HR17 deoxyribozyme-catalyzed formation of the branched standard. 
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molecular weight and architecture as the expected nucleopeptide ligation products from 
the selections (compare Fig. 3.2 and Fig. 3.3).  
The round 4 products from all four selections with 3′-phosphate substrates were 
assayed by PAGE. These assays were performed in an intermolecular format where the 
substrate is not covalently connected to the DNA enzyme. The migration rate of the 
products was compared to the branched standard described above. In each case, the 
substrate with either 3′-phosphate or 3′-OH was incubated with round 4 uncloned DNA 
pool and 5′-triphosphate-RNA. For Xaa = Ser, the ligation yields were 0.8% and 1.3%, 
respectively; for Tyr, the ligation yields were 5.8% and 7.0% (Fig. 3.4a). The similar 
ligation yields in Ser and Tyr when 3′-phosphate and 3′-OH substrates were used, 
suggested that the 3′-terminus of the DNA was not involved in the reaction. Also for both 
Ser and Tyr, the migration rate clearly indicated that a majority of the product is branched 
rather than linear; i.e., the reaction occurs at or near the tripeptide portion of the substrate, 
Figure 3.4. a) Assays for round 4 selection products formed using either 3′-phosphate (P) 
or 3′-OH tripeptide-containing substrate. Incubation conditions: 50 mM HEPES, pH 7.5, 150 
mM NaCl, 2 mM KCl, 20 mM MnCl2, and 40 mM MgCl2 at 37 °C for 20 h. b) Depiction of linear 
and branched product formation. 
 
a) b) 
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rather than at the 3′-terminus (Fig. 3.4b). For Ala, the ligation yields were 1.0% and 
<0.5%; for Lys, the ligation yields were 6.6% and <0.5%. In contrast to Ser and Tyr, the 
large difference in the yields in Ala and Lys using 3′-phosphate and 3′-OH substrates 
suggested that the 3′-terminus of the DNA is involved in the reaction. Also, the migration 
rate for products with Ala and Lys suggested a linear rather than branched product, 
consistent with the considerable yield difference in favor of the 3′-phosphate substrate. 
All four selections were continued for three additional rounds. In round 7, the product 
from 3′-phosphate reactivity now predominated in all four selections, although for each 
of the Tyr or Ser selections, a small fraction (3–7%) of the total product did still appear to 
result from the intended reaction at the amino acid (Fig 3.5). 
 To redirect the selection outcomes
19
 towards the desired reactivity of the amino acid 
side chains, we resumed the selections from round 8 using tripeptide-containing 
substrates that were terminated with an additional 3′-dideoxycytidine (3′-ddC) nucleotide, 
which lacks any strong nucleophile. In round 10 for the Tyr and Ser selections, 
substantial catalytic activity of each pool was observed (9% and 32%, respectively). 
Figure 3.5. Assays for round 7 selection products formed using either 3′-phosphate (P) 
or 3′-OH tripeptide-containing substrates. 
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The uncloned round 10 products from the 3′-ddC-redirected Ser and Tyr selections 
were assayed in the intermolecular format with the 3′-ddC substrates (Fig. 3.6). The 
ligation yields were 32% (Ser) and only 3.1% (Tyr), versus 32% and 9% observed in the 
corresponding selection rounds. For both selections, no activity was observed with a substrate 
containing Ala (a substrate containing Lys was also tested and found not to support any activity). 
However, the round 10 Ser selection pool did show 7.5% yield with Tyr substrate, and the round 
10 Tyr selection pool showed 3.5% yield with the Ser substrate. Individual deoxyribozymes 
from round 10 of the Tyr and Ser selections were isolated by cloning.   
3.2.2 Sequences of SerB1–SerB4 and TyrB1 deoxyribozymes 
From the Tyr selection, a single new sequence named TyrB1 was identified. From the 
Ser selection, four distinct sequences named SerB1–SerB4 were found. Fig 3.7 shows 
these sequences and their alignment.  
Figure 3.6. Assays of round 10 selection products (Xaa = Ser or Tyr) formed using 3′-
ddC tripeptide-containing substrates (Xaa = Ala, Ser, Tyr, or Lys). Note that the 
branched standard lacks the 3′-ddC that is present on the substrate, and therefore the 
branched product migrates slightly slower than the branched standard. 
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a) 
 
 
 
 
 
 
 
 
 
 
 
b) 
 
3.2.3 Characterization of SerB1–SerB4 and TyrB1 deoxyribozymes 
Kinetic assays were performed to test the catalytic efficiency of SerB1–SerB4 and 
TyrB1 deoxyribozymes. The DNA-peptide-DNA substrate is designated as the L (left-
hand) substrate, and the 5′-triphosphate-RNA substrate is designated as the R (right-hand) 
substrate. In these assays, the 5′-32P-radiolabeled L substrate was the limiting reagent 
relative to the deoxyribozyme (E) and the R substrate. The L:E:R ratio was <1:5:10, with 
the concentration of E equal to 0.5 µM in 20 µL assays. The incubation conditions were 
50 mM HEPES, pH 7.5, 150 mM NaCl, 2 mM KCl, 20 mM MnCl2, and 40 mM MgCl2 at 
37 °C. 2 µL aliquots of the reaction mixture were quenched at different times by adding 
EDTA and formamide. Progress of the reaction was monitored on PAGE. Fig. 3.8 shows 
one such kinetic gel image for the SerB2 deoxyribozyme with both Tyr and Ser-
deoxyribozyme sequence 
SerB1 5′-P3-ACGCCGTGTGTCTTACCGCGTACAGCGAATAGTT-P1-TGCAGCG-P4-P2-3′ 
SerB2 5′-P3-CTACAGTCGAGTAATGTAGTCAGCAAGATCGTCA-P1-TGTAGCG-P4-P2-3′ 
SerB3 5′-P3-CAGACGTACCGGACTGACAGCAAGATTGTTAGTA-P1-TGTAGCG-P4-P2-3′ 
SerB4 5′-P3-CACAGTATTGTGTCAGCAAGAAGTGGGATGTTTA-P1-TGTAGCG-P4-P2-3′ 
TyrB1 5′-P3-CGCCATTGTGGGTACAAAATGCGCCCGAGAAGTT-P1-CGCGGAA-P4-P2-3′ 
Figure 3.7. a) Architecture for TyrB1 and SerB1–SerB4 deoxyribozyme. P1, P2, P3 and P4 
regions are indicated. b) Sequences of SerB1–SerB4 and TyrB1 deoxyribozymes.  
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containing substrates. Such kinetic assays were performed for each of the four 
deoxyribozymes SerB1–SerB4 and TyrB1.  
Fig. 3.9 illustrates the progress of reactions catalyzed by SerB1, SerB2 and TyrB1 
with both Tyr- and Ser-containing substrates (four representative time points are shown). 
These yield versus time plots were generated from full kinetic data for each 
deoxyribozyme using a gel image similar to Fig. 3.8. SerB2, SerB3 and SerB4 have 
similar reactivity and selectivity (Fig. 3.10). The values of kobs were obtained by fitting 
this data directly to first-order kinetics; i.e., yield = Y(1 – e–kt), where k = kobs and Y is the 
final yield. However, when kobs was relatively low (<0.05 h
–1
), its value was estimated 
from a linear fit to the time points.  
TyrB1 functions with kobs = 0.30 h
–1
, 75% yield, and at least 600-fold selectivity for 
reaction of the Tyr side chain over Ser (Fig. 3.9). SerB1 has kobs = 0.24 h
–1
 and 82% 
yield, and the selectivity for Ser over Tyr is only 12-fold (Fig. 3.9). SerB2 through SerB4 
are all very similar in reactivity, with kobs = 0.4 h
–1
, ~80% yield, and merely two-fold 
selectivity for Ser over Tyr (Fig. 3.9 and Fig. 3.10). The difference in the selectivities of 
TyrB1 and SerB1–SerB4 for Ser and Tyr side chains can be attributed to the relative 
nucleophilicity of tyrosine and serine. Since tyrosine is more nucleophilic than serine, 
Figure 3.8. Representative kinetic assay PAGE image for SerB2 with Ser and Tyr-
containing substrates. t = 0, 4, 8, 15, 30 min; 1, 2, 4, 8, and 21 h. 
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TyrB1 is also highly selective for the tyrosine substrate. SerB1-SerB4 was selected with 
the less reactive serine and is thus less selective for serine.     
DNA catalysis generally requires divalent metal ions to support catalysis. During the 
selections that led to SerB1–SerB4 and TyrB1 deoxyribozymes, 20 mM MnCl2 and 40 
mM MgCl2 were both present during the key selection step. We further investigated if 
both of the metal ions are essential for catalysis. Ligation activity of all of these enzymes 
a) 
b) 
Figure 3.9. Catalytic activities of new deoxyribozymes for Tyr and Ser side chain reactivity. 
a) TyrB1 deoxyribozyme. In the tripeptide substrate, Xaa = Tyr () or Ser (). The ligation 
yield with Xaa = Ser at 21 h was <1%. The kobs value with Tyr was 0.30 h
–1
. b) SerB1 and 
SerB2 deoxyribozymes, with Xaa = Ser (, SerB1; , SerB2) or Tyr (, SerB1; , SerB2). kobs 
values: SerB1, 0.24 h
–1
 with Ser and 0.020 h
–1
 with Tyr; SerB2, 0.40 h
–1
 with Ser and 0.17 h
–1
 
with Tyr. Data for SerB3 and SerB4 were similar to that for SerB2 (Fig. 3.10). For all gel 
images, t = 0, 1, 5, and 21 h.  
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was measured in the presence of either Mg
2+
 or Mn
2+
 alone and compared to the activity 
when both metal ions were present together. Fig. 3.11 clearly shows that all of these new 
deoxyribozymes require Mn
2+
 for catalysis, whereas Mg
2+ 
is dispensable.  
Because Mn
2+
 is a cofactor required for activity of SerB1–SerB4 and TyrB1 
deoxyribozymes, its Kd,app was determined. Kd,app of a metal ion is determined by plotting 
the rate constants at different concentration of metal ion (Fig. 3.12). Thus, pseudo-first-
order rate constants, kobs, were measured for all five deoxyribozymes at different 
concentration of Mn
2+
. The values of kobs were obtained by determining the kinetics of 
each deoxyribozyme at different concentration of Mn
2+
 and then plotting yield versus 
time curves similar to Fig. 3.9b.  
Above 20–60 mM Mn2+ for all five deoxyribozymes, activity suppression was 
observed, via a decrease in ligation yield typically accompanied by a decrease in kobs. The 
   
   
   
   
Figure 3.10. Kinetic plots for SerB3 and SerB4. Xaa = Ser (, SerB3; , SerB4) or Tyr (, 
SerB3; , SerB4). kobs values: SerB3, 0.40 h
–1
 with Ser and 0.17 h
–1
 with Tyr; SerB4, 0.37 
h
–1
 with Ser and 0.14 h
–1
 with Tyr. 
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Figure 3.12. Determinations of Kd,app(Mn
2+
) for the SerB1–SerB4 and TyrB1 
deoxyribozymes. Assays were performed in 50 mM HEPES, pH 7.5, 150 mM NaCl, and 2 
mM KCl additionally containing 0–60 mM Mn
2+
 at 37 °C. Data were fit to the conventional 
curve kobs = kmax  [Mn
2+
] / (Kd + [Mn
2+
]).  
Figure 3.11. Ligation assays for the SerB1–SerB4 and TyrB1 deoxyribozymes in 50 mM 
HEPES, pH 7.5, 150 mM NaCl, 2 mM KCl and either 40 mM Mg
2+
, 20 mM Mn
2+
, or 20 mM 
Mn
2+
 + 40 mM Mg
2+
 (i.e., "mix") at 37 °C. The 21 h timepoints are shown using the 3′-ddC 
tripeptide-containing substrates with Xaa corresponding to the selection experiment.  
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data points for which such suppression was evident were excluded from the plots. The 
illustrated data allow the conclusion that Kd,app is >10 mM for each of SerB1–SerB3, 
15 ± 3 mM for SerB4, and 19 ± 4 mM for TyrB1. No Mg
2+
 was included in these 
experiments.  
We then tested the activity of all five deoxyribozymes with alanine-, serine-, tyrosine- 
and lysine-containing tripeptide substrates. All five deoxyribozymes were inactive with 
the lysine nucleophile and with the alanine-containing substrate used as a negative 
control.  
3.2.4 Characterization of products formed by TyrB1 and SerB1–SerB4 
deoxyribozymes 
MALDI-TOF mass spectrometry was used to corroborate the product assignments for 
the TyrB1, SerB1, and SerB2 deoxyribozymes (Fig. 3.13). In all three cases, the observed 
mass was within experimental error of the expected value for the assigned product. 
Figure 3.13. MALDI-TOF mass spectrometry of the TyrB1, SerB1, and SerB2 ligation 
products.  
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Biochemical assays were performed to provide additional evidence regarding the 
substrate reaction site for the SerB1 ligation product. These assays involved treatment of 
each ligation product with 80% aqueous acetic acid, which is known to hydrolyze 
phosphoramidate (P–N) bonds.20 These reactions were performed at 25 oC in a reaction 
volume of 100 l and then the DNA was precipitated using ethanol.  
The tripeptide-containing substrate has a phosphoramidate linkage directly to the 5′-
side of the tripeptide (Fig. 3.14). Therefore, phosphoramidate hydrolysis should lead to a 
readily predicted PAGE pattern if the product has the Tyr/Ser residue of the tripeptide-
containing substrate attached directly to the RNA substrate. Furthermore, the observed 
pattern should depend on whether the tripeptide-containing substrate was initially 5′-32P-
radiolabeled or 3′-32P-radiolabeled. For 5′-radiolabeling the phosphoramidate linkage is 
between the 
32
P-radiolabel and the tripeptide, whereas for 3′-radiolabeling the tripeptide 
is between the phosphoramidate linkage and the 
32
P-radiolabel. In addition, ligation 
products were synthesized using a substrate that has a second phosphoramidate linkage 
between the two T nucleotides immediately to the 3′-side of the tripeptide (Fig. 3.14); 
prepared by incorporating two nonadjacent 5′-NH2-T phosphoramidite monomers instead 
of only one such monomer during solid-phase synthesis of the tripeptide-containing 
substrate). For DNA-catalyzed ligation products prepared using this alternative substrate, 
phosphoramidate hydrolysis should cleave the tripeptide region (now connected to the 
RNA substrate) from the 
32
P radiolabel regardless of whether the label is at the 5′- or 3′-
end of the substrate. The assay outcomes were entirely in accord with expectations (Fig. 
3.14 c and d), supporting the nucleopeptide linkage assignments. 
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Figure 3.14. Biochemical assays to support the assignment of substrate reaction site for 
the SerB1 ligation products. a) Tripeptide-containing substrate with a single 
phosphoramidate (P–N) linkage on the 5′-side of the tripeptide, as used during selection 
and all other assays. b) Tripeptide-containing substrate with a second phosphoramidate 
linkage incorporated on the 3′-side of the tripeptide. c) and d) Treatment of the SerB1 
ligation products, made using the substrates of panels a and b, respectively, with 80% 
aqueous AcOH to cleave the phosphoramidate linkage(s). S = substrate; P = product. 
Z denotes the Ala-Ser-Ala tripeptide portion of the substrate. The incubation time (5 h) 
was chosen to cleave only a fraction of the potentially cleavable P–N bonds, which allows 
observation of both unhydrolyzed and hydrolyzed ligation product. 
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3.2.5 Investigation of substrate specificity of SerB1 and SerB2 deoxyribozymes 
The SerB1 and SerB2 deoxyribozymes were further investigated to determine their 
positional selectivities when presented with substrates that have more than one competing 
Ser side chain. A series of DNA-peptide-DNA substrates were synthesized with various 
combinations of Ser (S) and Ala (A) residues. The peptide region was either a single 
amino acid (S); a dipeptide (AS, SA, or SS); a tripeptide (SAA, the parent ASA, AAS, 
SSA, or ASS); or a tetrapeptide (ASAA, AASA, or ASSA, each of which has S at either 
or both of the two middle positions). SerB1 and SerB2 showed similar positional 
selectivity profiles (Fig. 3.15). Overall, for each deoxyribozyme, the reactivity depended 
Figure 3.15. Side chain positional selectivity for serine hydroxyl groups by the (a) SerB1 
and (b) SerB2 deoxyribozyme. Each plot is labeled with the identity of the 1–4 amino acids 
located at the 3HJ intersection.  
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on the length of the peptide region as well as the position(s) of the serines. Including only 
a single Ser residue led to only 0.7% ligation yield in 20 h, whereas certain dipeptide, 
tripeptide, and tetrapeptide sequences led to high yields. Each deoxyribozyme was able to 
discriminate between different peptide sequences of the same length but different Ser 
placement. For the dipeptide substrates, only SA and SS reacted well whereas AS reacted 
extremely poorly, demonstrating that these DNA catalysts can distinguish between two 
spatially adjacent Ser side chains. Similarly, for the tripeptide substrates, substantial 
discrimination was observed. The ASA substrate was utilized much better than the SAA 
substrate, whereas AAS was essentially unreactive. The tripeptide substrates with two 
adjacent Ser residues, SSA and ASS, each had high ligation rates and yields, consistent 
with reaction of either of the first two Ser residues and also consistent with no 
suppression of reactivity when Ser is located at the third position. Finally, the tetrapeptide 
substrates AASA and ASSA were used rather well whereas ASAA was used more 
poorly, showing tolerance of a peptide region larger than that present during the selection 
process.  
3.2.6 Progress of selection involving Lysine substrate 
In parallel with the efforts on Ser and Tyr, the Lys selection (refer to Section 3.2.1) 
was also resumed from round 8 using the corresponding Ala-Lys-Ala substrate termined 
with 3′-ddC. In round 13, 12% ligation activity was observed. On the basis of PAGE 
migration rates, the uncloned products have a linkage to the RNA substrate that is either 
within or near the tripeptide region (Fig. 3.16a). However, a substrate with Xaa = Ala 
was nearly as reactive as the substrate with Xaa = Lys, suggesting that the linkage to the 
RNA was created not directly at the Lys side chain but instead at a nearby functional 
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group. Upon cloning, a single deoxyribozyme sequence (13LS3) was identified and 
found to form a product in only 6% yield over 21 h in the presence of 20 mM Mn
2+
 and 
40 mM Mg
2+
. Similar results were obtained when 20 mM Mn
2+
 was used instead of Mn
2+
 
and Mg
2+
. The 13LS3 product appears to have the same connectivity as the product from 
the uncloned Lys selection pool (Fig. 3.16b). In addition, as observed for the uncloned 
pool, Xaa could be either Lys or Ala, indicating that the Lys side chain is not providing 
the nucleophile.  
To further confirm that lysine is not participating in the reaction catalyzed by the 
13LS3 deoxyribozyme, the 13LS3 product was synthesized with Xaa = Lys. This product 
was then reacted by reductive amination with a 35-mer 3′-aldehyde-DNA (generated via 
NaIO4 oxidation of 3′-riboA terminated DNA) in the presence of Ni
2+
 and NaCNBH3. 
Figure 3.16. Ligation assays related to the Lys selection. a) Ligation reactions with the 
uncloned round 13 pool, using the Ala-Xaa-Ala 3′-ddC substrate with Xaa = Ala, Ser, Tyr, 
or Lys. Assays were performed in 50 mM HEPES, pH 7.5, 150 mM NaCl, 2 mM KCl, 20 
mM Mn
2+
, and 40 mM Mg
2+
 at 37 °C for 20 h. Ligation yields (left to right) were 4%, 2%, 
2%, and 6%. b) Analogous ligation reactions with the 13LS3 deoxyribozyme. Ligation 
yields (left to right) were 4%, <0.5%, 2%, and 6%. Similar results were observed when 20 
mM Mn
2+
 alone was used in place of Mn
2+
 and Mg
2+
. 
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See Section 2.2.2 for a detailed procedure for reductive amination. Fig. 3.17 clearly 
shows that a free aliphatic amine is present in the 13LS3 product that can undergo 
reductive amination.  
Some instability of the 13LS3 ligation product was evident, leading to regeneration of 
a variable amount of the original substrate (i.e., the tripeptide-containing substrate not 
attached to its RNA ligation partner) in the final product sample used for the Fig. 3.17 
assays (see lanes marked ―P‖ in Fig. 3.17). This product instability appears to be 
associated with the gel extraction conditions used after PAGE. Extraction in the 
conventional TEN buffer (10 mM Tris, pH 8.0, 300 mM NaCl, 1 mM EDTA) led to 40–
50% substrate regeneration, whereas extraction in buffers of lower pH value (e.g., 10 mM 
HEPES, pH 7.0 or 10 mM NaOAc, pH 4.6) led to only 10–20% substrate regeneration. 
This instability of the 13LS3 product appears to be associated with the nature of the 
chemical bond between the peptide-containing substrate and the RNA molecule.  
Figure 3.17. Reductive amination of the 13LS3 ligation product (prepared from the Ala-Lys-
Ala 3′-ddC substrate), demonstrating that the product retains an aliphatic amine functional 
group. S = substrate; P = product. Lys denotes the second amino acid of the Ala-Lys-Ala 
tripeptide. See text for explanation of the regenerated substrate band that appears in the 
lanes for the 13LS3 product. 
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We then sought to determine the site of reaction in DNA-peptide-DNA conjugate. To 
accomplish this, 80% acetic acid cleavage assays (Fig. 3.18) analogous to those described 
above for the SerB1 product (Fig. 3.14) were performed with the 13LS3 product. As for 
the SerB1 product, the 13LS3 product was isolated by PAGE from a reaction sample that 
used either 5′-32P-radiolabeled or 3′-32P-radiolabeled tripeptide-containing substrate (5′-
radiolabel from -32P-ATP and T4 PNK; 3′-radiolabel from -32P-dCTP and terminal 
Figure 3.18. Treatment with 80% acetic acid of the 5′- or 3′-
32
P-radiolabeled 13LS3 product 
to determine its connectivity. The product was prepared using either the Ala-Ala-Ala or Ala-
Lys-Ala substrate (Z = tripeptide). Each product led to essentially the same assay pattern. 
Note the difference in position of the cleavage band formed from the two 3′-radiolabeled 
substrates; this difference arises because Ala or Lys is retained within the labeled 
fragment after acetic acid treatment. Also note that the cleavage band formed from each of 
the 13LS3 products (either 5′- or 3′-radiolabeled) is due to the regenerated substrate 
present within the product sample. The upper bracketed areas denote regions of the gel 
where either the 5′- or 3′-
32
P-radiolabeled 13LS3 product would be expected to provide an 
acetic acid cleavage band, if 13LS3 were to attach the 5′-triphosphate-RNA to the DNA 
portion of the substrate anywhere either to the left or the right of the tripeptide region. 
 61 
deoxytransferase). A substantial amount of tripeptide-containing substrate was 
regenerated by spontaneous cleavage of the product during its isolation from PAGE, as 
described above. The 
32
P-radiolabeled product was then incubated in 80% acetic acid for 
5 h. For the 5′-32P-radiolabeled product, no band corresponding to P–N cleavage of the 
product was observed, indicating that the linkage between the peptide-containing 
substrate and the 5′-triphosphate-RNA is not formed to the 5′-side of the 
phosphoramidate group. Similarly, for the 3′-32P-radiolabeled product, no band 
corresponding to P–N cleavage of the product was observed, showing that the new 
linkage is not formed to the 3′-side of the phosphoramidate group. Taken together, these 
two observations rule out any DNA nucleobase of the tripeptide-containing substrate (or 
any internucleotide phosphate group) serving as the nucleophile to attack the 5′-
triphosphate-RNA. This places the focus on the phosphoramidate functional group itself 
as the likely nucleophile.  
On the basis of a report by Moffatt and Khorana
21
 and considering the properties of 
the 13LS3 product, the 13LS3 product was assigned as 1 (Fig. 3.19), which contains an 
unusual pyrophosphoramidate linkage. Moffatt and Khorana reported the formation of 2 
(Fig. 3.20) by slow self-condensation of adenosine 5′-phosphoromorpholidate; i.e., attack 
of a phosphoramidate into an activated 5′-phosphorus (reaction A). This reaction is 
directly analogous to formation of 1 by DNA-catalyzed attack of the phosphoramidate 
linkage of the tripeptide-containing substrate into 5′-triphosphate-RNA (reaction B), 
thereby providing a chemical precedent for the DNA-catalyzed reaction leading to 1. 
Moffatt and Khorana also reported that a simple phosphodiester is much less nucleophilic 
towards adenosine 5′-phosphoromorpholidate than is the phosphoromorpholidate itself. 
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Consistent with this, we do not observe any DNA phosphodiester group within the 
tripeptide-containing substrate attacking the 5′-triphosphate-RNA. 
Moffatt and Khorana reported that 2 is generally stable to base but eventually 
hydrolyzes (e.g., 42% cleavage in 1 N NaOH at room temperature for 8 h), forming 
Figure 3.19. Assigned product 1 formed by the 13LS3 deoxyribozyme. 
Figure 3.20. Comparison of reactions to form 2 (reaction A, ref 21) and 1 (reaction B, 
present studies). Note that both 2 and 1 have pyrophosphoramidate linkages formed by 
attack of a phosphoramidate (red/gold) into an activated 5′-phosphorus (blue, with black 
leaving group). 
2 
1 
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adenosine 5′-phosphate and adenosine 5′-phosphoromorpholidate. In acid, 2 was found to 
degrade only rather slowly, forming P
1
,P
2
-diadenosine-5′-pyrophosphate by P–N 
hydrolysis in 1 N HCl at room temperature, conditions under which adenosine 5′-
phosphoromorpholidate itself was rapidly hydrolyzed. Therefore, 2 undergoes acid-
catalyzed P–N bond cleavage much more slowly than a simple phosphoramidate. These 
properties of 2 are consistent with the assignment of 1 as the 13LS3 product. Importantly, 
the failure to observe any 80% acetic acid cleavage of the new linkage in 1 (Fig. 3.18) is 
consistent with the acid resistance of 2. 
3.3 Summary 
We have shown for the first time that DNA can catalyze covalent modification 
reactions involving the serine side chain. Previous efforts from our lab revealed DNA-
catalyzed tyrosine reactivity, whereas serine proved refractory to catalysis.
14
 Here, by 
relaxing the structural preorganization via placing a larger peptide region within the 3HJ 
architecture, we obtained robust DNA-catalyzed reactivity of the Ser side chain. We also 
showed that deoxyribozymes can discriminate between Ser and Tyr when presented at the 
same amino acid position, and we showed that deoxyribozymes can distinguish between 
multiple Ser side chains that are located close to each other in space. In parallel, our 
results indicate that obtaining DNA-catalyzed Lys side chain reactivity is relatively 
difficult, at least under the conditions used in our selection experiments, leading to 
reactivity of a much less nucleophilic nearby phosphoramidite functional group instead of 
the Lys side chain. To address the difficulties associated with obtaining deoxyribozymes 
that can catalyze reactions involving lysine side chains, we further investigated the 
reactivity of lysine with a more reactive electrophile as discussed in Chapter 4.  
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Chapter 4: Toward Identification of Deoxyribozymes that Catalyze   
Reactions Involving Amine Nucleophiles 
4.1 Introduction  
The ability of DNA to catalyze reactions involving amine-containing side chains, 
particularly the lysine side chain, was explored in the investigations described in this 
chapter. Covalent modification of lysine is important in multiple biological processes; 
post-translational modifications (PTMs) of lysine are more abundant in nature than PTMs 
of any other amino acid.
1
 In addition to the well-studied lysine acetylation,
2-4
 
methylation
5,6
 and ubiquitination,
7,8
 recently a variety of other PTMs of lysine have been 
identified. These include lysine formylation,
9
 propionylation,
10
 butyrylation
11
 and 
succinylation
1
. These covalent modifications of lysine have important functional and 
regulatory implications. For example, lysine acetylation modulates gene expression in 
various eukaryotes; histone acetyl transferases (HATs)
12
 and histone deacetylases 
(HDACs)
13
 that catalyze acetylation and deacetylation respectively of lysine residues on 
histones are important drug targets for different carcinomas
14-16
 and neurodegenerative 
diseases.
17
 Recently, lysine acetylation was also discovered in prokaryotes and has been 
found to control many cellular process in bacteria.
18
   
Since lysine plays such important roles in several cellular processes, the development 
of artificial lysine-modifying enzymes could have important therapeutic implications. 
These enzymes could be used to modulate important cellular functions associated with 
lysine. Although multiple naturally occurring protein-based enzymes exist that catalyze 
chemical modification of lysine, analogous nucleic acid-based enzymes are not known. 
Thus, in seeking to develop DNA-based enzymes for lysine modification we also aimed 
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to address the fundamental question of whether nucleic acids can catalyze reactions 
involving amine nucleophiles.  
We designed in vitro selections to identify deoxyribozymes that can catalyze 
nucleophilic attack of the lysine side chain on electrophilic substrates. In a preliminary 
effort described in Chapter 3, the 5′-triphosphate-RNA electrophile was used. The 
selection experiments were performed in a preorganized three-helix-junction (3HJ) 
architecture. However, these attempts were unsuccessful. Additional attempts by others 
in our laboratory to identify deoxyribozymes that can catalyze the reaction of  lysine with 
5′-triphosphate-RNA electrophile using other structural arrangements have also not been 
successful.
19,20
  
It is interesting to note that even though even though numerous nucleic acid-based 
enzymes are known that catalyze reactions involving hydroxyl nucleophiles,
19-23
 such 
enzymes are rare for amine nucleophiles. Only one example is known for the latter, 
where a ribozyme catalyzes a reaction involving the N-terminal amine of a peptide with 
5’-triphosphate-RNA electrophile. Notably, in this report, lysine present in the substrate 
appears to be unreactive.
24
  
We recently discovered multiple deoxyribozymes that catalyze reactions involving 
tyrosine. The pKa value of tyrosine hydroxyl and conjugate acid of lysine are very similar 
(Fig. 4.1). Although basicity and nucleophilicity are expected to be correlated, lysine 
appears to be refractory towards catalysis. One of the differences between tyrosine and 
lysine is that the former is nucleophilic in protonated as well as deprotonated forms (Fig. 
4.1). In contrast, only the deprotonated form of lysine is nucleophilic and the protonated 
form has no lone pair of electrons available for the nucleophilic reaction. Also, the 
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negatively charged phosphate backbone of DNA would stabilize the positively charge 
conjugate acid of lysine. In fact in nature, the electrostatic interaction between the 
positively charged lysines in histones and the phosphate backbone of DNA is important 
for DNA packaging and in all such cases lysine predominantly exists in the positively 
charged form.
25
 
In nature, whenever the amine group of lysine is involved in a nucleophilic reaction it 
is found to be embedded in hydrophobic pockets in proteins.
26
 This can decrease the pKa 
of the amine group to as low as 5.3,
26
 thus favoring the deprotonated form of lysine. It 
might be inherently difficult for DNA to form similar hydrophobic pockets due to the 
high negative charge of the phosphate backbone.  
Despite the challenges discussed above, we explored the possibility of identifying 
deoxyribozymes that can catalyze nucleophilic reactions involving amines. In earlier 
attempts to identify deoxyribozymes for catalyzing the reaction of lysine-containing 
Figure 4.1. Comparison of pKa of tyrosine and conjugate acid of lysine. Both the 
protonated and deprotonated forms of tyrosine are nucleophilic. Only the deprotonated 
of lysine is nucleophilic.    
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substrates, only one particular electrophile, 5′-triphosphate-RNA was examined. 
Although 5′-triphosphate-RNA has been employed as an electrophile in several DNA-
catalyzed reactions,
19,21,27-31
 it may not be ideal for seeking a reaction with lysine. For 
reaction of lysine with triphosphate electrophile, it is necessary that they are spatially 
close to each other. At pH 7, the triphosphate electrophile would be negatively charged, 
and the proximity of lysine and triphosphate could promote the protonation of lysine by 
increasing its pKa, making it unsuitable for nucleophilic attack (Fig 4.2). For hydroxyl 
nucleophiles, a similar increase in pKa would result in the protonated form, which can 
retain its nucleophilicity due to the availability of the lone pair on oxygen.  
We thus sought deoxyribozymes that can catalyze the reaction of lysine with a more 
reactive as well as less negatively charged electrophile: 2′,3′-cyclic phosphate DNA (Fig 
4.3). 2′,3′-cyclic phosphate is known to have been used as an electrophile in other 
deoxyribozyme-catalyzed reactions.
32,33
 
Figure 4.2. Spatial proximity of lysine to triphosphate electrophile will promote 
protonation of lysine and render it non-nucleophilic.  
 70 
4.2 Results and Discussion 
4.2.1 Selection design with cyclic phosphate electrophile 
 
In vitro selections were designed to identify deoxyribozymes that can catalyze 
reaction of four different nucleophiles: lysine-containing tripeptide, 5′-amino-T-
terminated DNA, serine-containing tripeptide and 5′-hydroxyl-DNA with 2′,3′-cyclic 
phosphate electrophile (Fig. 4.4). The 5′-hydroxyl-DNA substrate was used as a positive 
control because deoxyribozymes that catalyze the reaction of hydroxyl with 2′,3′-cyclic 
Figure 4.4. Selection format for identification of deoxyribozymes that can catalyze 
reaction of amine nucleophiles with 2′,3′-cyclic phosphate electrophile.  
Figure 4.3. Comparison of chemical structures of 2′,3′-cyclic phosphate and 5′-
triphosphate electrophiles. The ring strain in cyclic phosphate makes it more reactive 
compared to triphosphate electrophile.  
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phosphate are known.
32,33
 Selections involving 5′-amino-T-terminated DNA substrate 
were expected to give information about the fundamental reactivity of amine functional 
groups in the context of DNA catalysis. Selections with serine and lysine-containing 
tripeptide substrates would examine the ability of DNA to catalyze reactions of serine 
hydroxyl and lysine amine in a peptide substrate with 2′,3′-cyclic phosphate electrophile.   
Seven different selections, designated RA-RG, were designed with different metal 
ion/pH combinations and these four substrates (Fig 4.5). The ability of DNA to catalyze 
reaction of the lysine side chain was examined under three different conditions: (i) 40 
mM Mg
2+
/20 mM Mn
2+
 at pH 7.5; these conditions were adopted because Mg
2+ 
and Mn
2+
 
have earlier been found to promote the nucleophilic attack of serine and tyrosine 
hydroxyl on 5′-triphosphate-RNA,19,21 (ii)  40 mM Mg2+ at pH 9.0; these conditions were 
adopted because higher pH is expected to enhance the reactivity of lysine and Mn
2+ 
cannot be used because it gets oxidized at pH 9, (iii) Lanthanide ions, Ce
3+
, Eu
3+
, Yb
3+
 
(designated as Ln
3+
 here onwards) and Zn
2+
 at pH 7.5; these conditions were used to 
explore the ability of Ln
3+ 
to promote DNA catalysis. Due to the limitation on the number 
of selections that can be performed in parallel, a subset of the above conditions was used 
to identify deoxyribozymes with the other three nucleophiles (Fig 4.5).  
Lysine- and serine-containing tripeptides were tethered to a DNA anchor, which in 
turn, attaches to the DNA pool, thus enabling the selection process. The DNA anchor has 
a hexa(ethylene glycol) linker connected to a free thiol group at its 5′-end and three 
ribonucleotides at its 3′-end. The free thiol group at the 5′-end of the DNA anchor is 
conjugated to the cysteine containing tripeptide, CKA (Fig. 4.6) and similarly, also to 
CSA in separate reactions. The detailed procedure for performing this conjugation
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Figure 4.5. Selection design for identification of deoxyribozymes that can catalyze 
reactions involving amine nucleophiles.  
Figure 4.6. Tripeptide (CKA) tethered to 5′-thiol DNA. The N-terminus of the peptide is 
blocked by acetyl group and the C-terminus is blocked by N-methyl amide.  
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reaction is described in Chapter 2, Section 2.2.2. These peptide-DNA conjugates were 
employed as substrates during the selection. The three ribonucleotides at the 3′-end of 
DNA anchor are required for ligating the DNA anchor to the DNA pool using T4 RNA 
ligase. The 5′-amino-T-terminated DNA and 5′-hydroxyl-DNA substrates were 
synthesized using the solid-phase method discussed in Chapter 2, Section 2.2.1.  
    The 2′,3′-cyclic phosphate-terminated DNA substrate was synthesized using a 
precursor DNA that has an internal ribonucleotide linkage. This linkage was cleaved 
enzymatically by the E1111 deoxyribozyme, an analog of the RNA-cleaving 8-17 
deoxyribozyme (Fig. 4.7).
34
 The cleavage reaction was performed by incubating the 
internal riboU-containing precursor DNA with 1.5-fold excess of E1111 deoxyribozyme 
in 50 mM HEPES, pH 7.5, 150 mM NaCl, 2 mM KCl and 10 mM MgCl2 for 12 h at 37 
o
C. The cleavage products, 2′,3′-cyclic phosphate-terminated DNA and 5′-hydroxyl 
DNA, were separated by PAGE.  
The general selection procedure and the steps involved are described in Chapter 2. In 
brief, at the outset of each round of the selection process, the 3′-ribo-terminated DNA 
was ligated via its 3′-terminus to the 5′-end of the deoxyribozyme pool strand using T4 
RNA ligase. Any DNA sequence that successfully catalyses the reaction of the amine or 
hydroxyl nucleophile with the 2′,3′-cyclic phosphate-terminated DNA (Fig. 4.4) gains 
Figure 4.7. E1111-catalyzed cleavage of internal ribo-containing DNA to generate 2′,3′-
cyclic phosphate-terminated DNA.  
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molecular weight due to the added length of the 2′,3′-cyclic phosphate-terminated DNA 
strand, hence is separable from catalytically inactive DNA sequences by PAGE. During 
the key selection step of each round, the incubation conditions were, (i) 50 mM HEPES, 
pH 7.5, 150 mM NaCl, 2 mM KCl, 20 mM MnCl2 and 40 mM  MgCl2 (ii) 50 mM CHES, 
pH 9.0, 150 mM NaCl, 2 mM KCl and 40 mM  MgCl2, (iii) 50 mM HEPES, pH 7.5, 150 
mM NaCl, 2 mM KCl, 1 mM ZnCl2 and10 M LnCl3. All selection experiments were 
performed at 37 °C for 12 h.  
4.2.2 Progress of RA-RG selections 
Detectable catalytic activity (>1%) was first observed in round 3 of six of the seven 
selections and reached around 50% by round 6 (Fig. 4.8). No activity was observed in the 
selection that employed Ln
3+
 and Zn
2+
 as cofactor. The selection standard was an 
oligonucleotide with the same number of nucleotides as the expected product. However, 
the selection product migrates slower than the standard, possibly due to a difference in 
architecture. Fig. 4.9 shows the progress of these selections.  
Figure 4.8. Selection PAGE for round 6 of RA-RG selections. The selection standard, std, 
was an oligonucleotide with the same number of nucleotides as the expected product. 
Figure 4.9. Graphical depiction of progress of RA-RG selections. 
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We assayed the uncloned pools from round 7 of these selections in intermolecular 
format (in trans), i.e., with the DNA pool not connected to the substrate. These assays 
were performed using the 3′-pCp-32P-radiolabelled right-hand substrate (R substrate) 
(Fig. 4.10). The 3′-32P-radiolabeled R substrate was the limiting reagent relative to the 
DNA pool and the L substrate in the assays. The incubation conditions were the same as 
those in the corresponding selections. Each of the uncloned DNA pools was tested with 
five different substrates: lysine-containing substrate, serine-containing substrate, 5′-
Figure 4.10. Assays in trans, with DNA pool not connected to the substrate (see top of 
figure for schematic of experimental design). 3′-Radiolabelled right-hand substrate was 
utilized in this assay. The difference in the migration rate of the lower band is due to the 
differences in the molecular weight and charge of various right-hand substrates. Each of 
the six DNA pools from round 7 of the selection were assayed for their catalytic 
properties with five different substrates.  
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amino-T-terminated DNA, 5′-hydroxyl DNA substrates and the alanine-containing 
substrate (as a negative control). The DNA pools tested in trans did not show activity and 
no product bands were observed. Similar assays were also performed with 5′-32P-
radiolabeled L substrate and no activity was observed in these assays (Fig. 4.11).  
This lack of reactivity in trans suggested that the connection between the 
deoxyribozyme and the substrate is important for catalysis. We then examined if the 
activity observed in cis (same as observed during selections, Fig. 4.8) depends on the 
type of nucleophile at the 5′-end of the right-hand substrate. The right-hand substrate in 
the selections was replaced by a 5′-disulphide containing DNA (Fig. 4.12). This 5′-
Figure 4.11. Assays in trans, with DNA pool not connected to the substrate (see top of 
figure for schematic of experimental design). 5′-Radiolabelled left-hand substrate was 
utilized in this assay. Four DNA pools from round 6 of the selection were assayed for 
their catalytic properties with two different substrates.  
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disulphide containing DNA is the precursor DNA for right-hand substrates in the  RA, 
RB, RC and RF selections. This oligonucleotide strand, which has three ribonucleotides 
at its 3′-end was ligated to each DNA pool and the selection reaction was performed. The 
DNA pools were active in cis with this 5′-disulphide containing DNA substrate. The 
activity observed in cis is independent of the 5′-nucleophile in the right-hand substrate 
and presumably a result of the reaction of other nucleophiles present in the right-hand 
substrate.  
These observations lead us to postulate that the observed activity is due to the 
nucleophilic attack of one of the 2′-hydroxyls of the ribose sugars present in the loop that 
connects the deoxyribozyme pool and the right-hand substrate, on the 2′,3′-cyclic 
phosphate electrophile in the left-hand substrate (Fig. 4.13). This conclusion is consistent 
with lack of activity in trans, when the deoxyribozyme pool is not connected to the 
Figure 4.12. Assays in cis, with DNA pool connected to the substrate (see top of figure 
for schematic of experimental design). The DNA pools from round 7 of all the selections 
were generated by PCR that has -
32
P dCTP. These DNA pools were then ligated to a 
modified substrate that lacks the original nucleophile used during the selections.  
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substrate and the loop is absent. Also, because the reaction occurs far away from the 5′-
end of the right-hand substrate, the activity in cis will not depend on the nucleophile at 
the 5′-end of the right-hand substrate. We thus modified our selection design as described 
in the next section. 
4.2.3 Modified selection design: Progress of SS-SZ selections 
To eliminate the DNA sequences that could catalyze the undesired reaction of 2′-
hydroxyl with 2′,3′-cyclic phosphate,  we modified our selection design. In the modified 
selection plan, even rounds of selection were performed by connecting the DNA pool to 
the 2′,3′-cyclic phosphate substrate as shown in Fig. 4.14, and odd rounds of selection 
were performed by connecting DNA pool to the DNA substrate bearing the nucleophile 
(Fig. 4.5). This alternation in the connectivity of the DNA pool to the substrate is 
Figure 4.13. Reaction of one of the 2′-hydroxyls of the ribose sugars present in the loop 
connecting the deoxyribozyme pool and the right-hand (R) substrate with the 
electrophile in the left-hand (L) substrate. This explains the absence of activity when the 
DNA pools are assayed in intermolecular format (in trans), where the connection 
between the R substrate (red) and the deoxyribozyme binding arm (brown) is absent.  
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expected to eliminate the emergence of DNA sequences that require the covalent 
connection between the DNA pool and the substrate to support catalysis.  
During even rounds of selection, ligation of the 2′,3′-cyclic phosphate substrate to the 
DNA pool was performed using T4 DNA ligase. The procedure for this ligation reaction 
involves using a DNA splint and is discussed in detail in Chapter 2, Section 2.1.2. The 
SS-SZ selections were analogues to RA-RG selections and were performed using a 
similar selection procedure as outlined in Section 4.2.1. 
Activity was first observed in round 5 of these selections. However, the selection 
product bands disappeared in round 6 and again showed up in round 7. Since this activity 
Figure 4.14. Modified selection design for identification of deoxyribozymes that can 
catalyze reactions involving lysine side chains.  
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was observed only in odd rounds of selection when the DNA pool is connected to the 
DNA bearing the nucleophile, it suggested emergence of deoxyribozymes similar to those 
resulting from the RA-RG selections (Fig. 4.13). Thus, alternating the connectivity of the 
DNA pool with the substrate was unsuccessful in eliminating sequences that catalyze the 
formation of side products (from reactions involving ribose 2′-hydroxyls).  
4.3 Summary and Future Directions 
The investigations described in this chapter highlight the challenges associated with 
identifying deoxyribozymes that catalyze reactions involving amine nucleophiles. In all 
selections, a side reaction involving the ribose 2′-hydroxyl dominated the DNA pool 
population. The emergence of this side reaction despite the presence of amine 
nucleophiles in the substrate highlights the challenges involved in identifying 
deoxyribozymes for reactions of these side chains. 
These studies suggest that future efforts to identify deoxyribozymes that can catalyze 
reactions involving amines would require the removal of the 2′-hydroxyls that were 
present in the substrate in these selections. These selections are in progress in our 
laboratory. It may also be worthwhile to explore the reaction of amines with other 
electrophiles, such as sugar-based electrophiles like UDP-GalNAc. Performing selections 
with new electrophiles would require the development of novel selection strategies to 
identify catalytic DNA molecules. 
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Chapter 5: Covalent Tagging of Phosphopeptides Using 
Deoxyribozymes
a
 
5.1 Introduction  
Protein/peptide phosphorylation is one of the most widespread post-translational 
modifications (PTMs) found in eukaryotes. The addition of a phosphate to tyrosine, 
serine and threonine side chains is catalyzed by enzymes called kinases that transfer the 
phosphate group of ATP to amino acid side chains. About 30% of the proteins in 
eukaryotic cells are subject to phosphorylation.
1
 Addition of a phosphate group to 
endogenous peptides and proteins is exploited in nature to control different cellular 
processes from cell growth
2
  and differentiation
3
 to cell death and apoptosis.
4
 
Phosphopeptides are also important in memory, and multiple kinases are associated with 
pathways involved in neuronal communication.
5
 Many other metabolic processes such as 
cellular energy flux regulation are also influenced by phosphorylation of proteins.
6
  
Malfunction of kinases can thus severely affect regulatory processes and lead to 
several diseases e.g., various types of carcinomas have altered phosphorylation events. 
Protein kinases are the second most important class of drug targets.
7
  There is enormous 
interest in assaying phosphorylation states of amino acids in proteins and peptides. Such 
assays are important for developing new therapeutics that target kinases, where the ability 
of a particular drug candidate to inhibit phosphorylation is in question, and also for 
developing new diagnostic tools where phosphoproteins (hereafter, this term includes 
                                                 
a
 The material described in this chapter is in preparation for publication. 
Sachdeva, A.; Silverman, S. K. Covalent tagging of phosphopeptides by phosphate-specific 
deoxyribozymes. 2011, in preparation for publication. 
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phosphopeptides) can be used as biomarkers for different diseases. For example, changes 
in the phosphoproteome can be a signature of different cancers.
8
 Assaying global changes 
in the phosphoproteome as well as measuring the extent of phosphorylation of particular 
proteins can thus provide vital information about several disease states, including 
developing cancers. 
Different methods have been developed to access phosphorylation of proteins and 
peptides. These can broadly be divided into two categories, (i) antibody-based methods 
and (ii) mass spectrometry-based methods.  
Antibodies that recognize specific phosphorylated proteins were first isolated in 
1981.
9
 Since then, many other phosphoprotein-specific antibodies have been identified 
and are utilized in western blotting and ELISA to detect and quantify specific 
phosphoproteins with very high sensitivity and selectivity. Although these methods are 
highly useful to detect phosphorylation of a particular protein in a sample, they have 
limited utility if changes in phosphorylation states of multiple proteins are to be 
measured. In addition, due to the difficulties associated with generation of antibodies and 
their long-term stability under room temperature conditions, these methods are cost-
intensive. Also, both ELISA and western blotting are laborious methods.  
The second most common method to detect phosphorylated proteins and peptides is 
mass spectrometry (MS). MS has been utilized to identify and sequence phosphoproteins. 
However, there are several inherent difficulties in the analysis of phosphoproteins using 
MS. Generally, electrospray ionization (ESI) MS is not performed in the negative mode 
for proteins due to poor ionization, and in the positive mode phosphoproteins ionize 
poorly due to the negative charge of the phosphate group.
10
 Also, phosphoproteins are 
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present in low abundance and thus their signals are difficult to observe in the high 
background of abundant non-phosphorylated proteins. Analyses of phosphoproteins by 
MS thus require enrichment methods that have been specifically developed for 
phosphoproteins. These methods include immobilized metal affinity chromatography 
(IMAC),
11
  phosphospecific antibody-based enrichment,
12
 chemical-modification-based 
methods such as -elimination of phosphoserine and phosphothreonine,13 and 
replacement of the phosphate group with biotinylated moieties.
14
 These methods suffer 
from some limitations. For example, the IMAC-based method is not very selective for 
phosphoproteins because peptides containing negatively charged amino acids coelute 
with phosphoproteins. Chemical-modification-based methods require multiple reactions 
for enrichment, hence are laborious. Therefore, newer and better methods for enrichment 
of phosphoproteins are required. 
We sought to identify deoxyribozymes that can covalently attach RNA molecules to 
phosphopeptides (Fig. 5.1). Development of such DNA enzymes can address some of the 
difficulties associated with current methods of phosphopeptide enrichment and detection. 
The advantages of low costs and ease of handling of deoxyribozymes can rival antibody-
based methods for phosphopeptide detection. However, for such applications, 
Figure 5.1. Seeking DNA enzymes that can specifically tag phosphopeptides. 
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deoxyribozymes have to be very specific for particular phosphopeptides. In contrast, 
nonspecific deoxyribozymes that are selective for the phosphate group can also be useful 
for tagging phosphopeptides with RNA. Two major advantages of attaching a nucleic 
acid molecule to phosphopeptides are as follows: 
(i) Nucleic acid-phosphopeptide conjugates can easily be isolated using antisense 
oligonucleotides.
15
  
(ii) Nucleic acid-phosphopeptide conjugates can directly be analyzed by MS. Nucleic 
acids are negatively charged, hence are analyzed by MS in negative mode. The MS 
analysis of nucleic acid-phosphopeptide conjugates is also performed in negative mode 
since the peptide forms only a small fraction of the conjugate. The background signal 
from other peptides that ionize well in positive mode would also be considerably reduced.  
5.2 Results and Discussion  
The selection design for identification of deoxyribozymes that can covalently tag 
phosphopeptides is shown in Fig. 5.2. A model hexapeptide, AAAY
p
AA, was used as a 
substrate. This hexapeptide was covalently attached via its N-terminus to a DNA anchor. 
The covalent attachment was achieved by reacting the N-terminal amine of the peptide 
with a 3′-dialdehyde DNA using reductive amination conditions (100 mM NaOAc, pH 
5.2, 50 mM NiCl2, 10 mM NaCNBH3). Details of this conjugation reaction are discussed 
in Chapter 2, Section 2.2.2. The chemical structure of the DNA-peptide conjugate is 
shown in Fig. 5.3a.  
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Figure 5.2. Selection format for identification of DNA enzymes that can covalently tag 
phosphopeptides with RNA. 
 
Figure 5.3. DNA-peptide conjugates used during the selection. a) Peptide directly 
conjugated to the 3′-terminus of DNA. b) Peptide conjugated to the 3′-terminus of DNA 
with an intervening HEG linker.  
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Three different selections, designated VM–VP, were performed (Fig 5.4). The two 
substrates that were used in these selections have the peptide either connected directly or 
via an intervening hexa(ethylene glycol) (HEG) linker (Fig 5.3b) to the 3′-terminus of the 
DNA anchor. The HEG linker increases degrees of freedom associated with the peptide, 
and thus increases the probability of identifying deoxyribozymes that can function 
withthe free peptide substrate and do not require the DNA anchor for catalysis. Selections 
with the substrate that has peptide directly attached to the DNA tether were performed 
under two different conditions: (i) pH 7.5 in presence of 40 mM Mg
2+
 and 20 mM Mn
2+
 
(VM selection), (ii) pH 9.0 in presence of 40 mM Mg
2+
 (VN selection). Similar metal 
ions and pH have been shown to support catalysis by DNA for other reactions.
16,17
   
Figure 5.4. Selection design for identification of DNA enzymes that can catalyze covalent 
tagging of phosphopeptides.  
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The general selection procedure and the steps involved are described in Chapter 2. 
Briefly, at the outset of each round of the selection process, the DNA-peptide conjugate 
was ligated via its 5′-terminus to the 3′-end of the deoxyribozyme pool strand using T4 
DNA ligase. The procedure for this ligation reaction involves using a DNA splint and is 
discussed in detail in Chapter 2, Section 2.1.2. The ligated deoxyribozyme pool was then 
incubated with 5′-triphosphate-RNA under the selection conditions. Any DNA sequence 
that successfully catalyses the reaction of the phosphate oxygen in the hexapeptide-
containing substrate with the 5′-triphosphate-RNA (as shown in Fig. 5.2) gains mass from 
the added length of the RNA strand, thus allowing its separation using PAGE. During the 
key selection step of each round, the incubation conditions were, (i) 50 mM HEPES, pH 
7.5, 150 mM NaCl, 2 mM KCl, 20 mM MnCl2 and 40 mM MgCl2, and, (ii) 50 mM 
CHES, pH 9.0, 150 mM NaCl, 2 mM KCl and 40 mM MgCl2. The reactions were 
performed at 37 °C for 12 h.  
5.2.1 Progress of VM-VP selections  
Detectable catalytic activity (>1%) was first observed in round 6 in two of the 
selection experiments, VM (Tyr
P
) and VP (HEG-Tyr
P
). Both selections employed a 
mixture of Mg
2+
 and Mn
2+
 at pH 7.5. Fig. 5.5 shows the round 7 selection gel image. The 
activity observed in VM and VP selections leveled off between 30-40% by round 10. 
Figure 5.5. Selection gel for round 7 of VM-VP selections. 
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Activity was also observed in trans, when the deoxyribozyme pool was not connected to 
the substrate (Fig. 5.6). Therefore these deoxyribozymes do not require the covalent 
attachment to the substrate for catalysis. The VN selection did not show any activity 
through round 11 and was terminated.  
The uncloned deoxyribozyme pools from the VM and VP selections were further 
examined for their selectivity for the phosphate group over hydroxyl group in the peptide 
substrate. The catalytic activity of deoxyribozyme pools from three different rounds of 
VM and VP selections was assessed with three different substrates: the DNA anchor 
alone, the DNA anchor-non-phosphorylated peptide (AAAYAA) conjugate, and the 
DNA anchor-phosphorylated peptide (AAAY
P
AA) conjugate (Fig. 5.6). These assays 
were important in determining which DNA pool should be cloned to identify individual 
Figure 5.6. Assays in trans (DNA pool not connected to the substrate) for VM and VP 
deoxyribozyme pools. DNA pools from different rounds of VM and VP selections were 
examined for their activity and selectivity for the phosphate group over hydroxyl group 
in the peptide substrate. All DNA pools examined are highly selective for phosphate, 
except for the 7VM deoxyribozyme pool, which shows 5% activity with the non-
phosphorylated peptide substrate.  
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deoxyribozymes. During rounds of selection, the population of DNA sequences can 
change from non-selective to highly selective or vice-versa. The 7VM deoxyribozyme 
pool included sequences that were less selective for the phosphate group (Fig 5.6). With 
the progress of selection these sequences were eliminated.  For all other deoxyribozyme 
pools that were tested, the DNA sequence population was highly selective for the 
phosphate group on the peptide substrate. This selectivity is critical for any future 
application of the deoxyribozymes to capture phosphorylated peptides. Individual 
deoxyribozymes from round 8 of the Tyr
P 
(VM) and HEG-Tyr
P
 (VP) selections were 
identified by cloning.   
5.2.2 Sequences of 8VM1 and 8VP1 deoxyribozymes  
DNA pools from round 8 of the Tyr
P 
(VM) and HEG-Tyr
P
 (VP) selections were 
cloned, and the sequences of individual clones were obtained. The cloning procedure is 
discussed in Chapter 2. For each of VM and VP selection only a single unique sequence 
was identified. Fig. 5.7 shows these sequences and their alignment.  
5.2.3 Characterization of 8VM1 and 8VP1 deoxyribozymes  
Kinetic assays were performed to determine the catalytic efficiency of the 8VM1 and 
8VP1 deoxyribozymes. The DNA-peptide substrate is designated as the L (left-hand) 
Figure 5.7. Sequences of 8VM1 and 8VP1 deoxyribozymes and their sequence 
alignments (generated using CLC sequence viewer). 
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substrate, and the 5′-triphosphate-RNA substrate is designated as the R (right-hand) 
substrate. In these assays, the 3′-32P-radiolabeled R substrate was the limiting reagent 
relative to the deoxyribozyme (E) and the L substrate. The R:E:L ratio was ~ 1:5:10, with 
the concentration of E equal to 0.25 µM. The incubation conditions were 50 mM HEPES, 
pH 7.5, 150 mM NaCl, 2 mM KCl, 20 mM MnCl2, and 40 mM MgCl2 at 37 °C. 2 µL 
aliquots of the reaction mixture were 
quenched at different time points. 
Progress of the reaction was 
monitored using PAGE. Fig. 5.8 
shows the kinetic assay gel image for 
8VM1 deoxyribozyme with both Tyr 
and Tyr
p
-containing substrates. The 
activity of 8VM1 and 8VP1 was 
measured with their parent substrates, 
DNA-AAAY
P
AA and DNA-HEG-
AAAY
P
AA respectively, and their 
non-phosphorylated analogs (Fig. 
5.9).  
Ligation yield versus time plots (Fig. 5.9) for both 8VM1 and 8VP1 were generated 
using gel images similar to those shown in Fig. 5.8.  These plots were fitted to first-order 
kinetics; i.e., yield = Y(1 – e–kt), where k = kobs and Y is the final yield. 8VM1 and 8VP1 
deoxyribozymes were highly selective for the phosphate group on the peptide substrate. 
For both deoxyribozymes, no activity (<0.1%) was observed with the non-
Figure 5.8. Representative kinetic assay PAGE 
image for 8VM1 deoxyribozyme with Tyr and 
Tyr
P
-containing substrates. t = 0, 15, 30 min; 1, 
2, 4, 8, 24, and 50 h. 
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phosphorylated substrates in 50 h. 8VM1 has kobs = 0.49 h
–1
 and 58% yield with the 
parent DNA-AAAY
P
AA substrate, and 8VP1 has kobs = 0.16 h
–1
 and 41% yield with the 
parent DNA-HEG-AAAY
P
AA substrate.  
8VM1 and 8VP1 deoxyribozymes were identified from selection experiments that 
employed Tyr
P
-containing substrates. We further examined if these deoxyribozymes can 
distinguish between Tyr
P
 and Ser
P
. Analogous Ser
P
-containing peptides were synthesized 
and conjugated to the DNA anchor. Kinetic assays were performed for 8VM1 and 8VP1 
using DNA-AAAS
P
AA and DNA-HEG-AAAS
P
AA substrates respectively (Fig. 5.10).  
8VM1 shows 7-fold selectivity for Tyr
P
- over Ser
P
-containing substrates. In contrast, 
8VP1 has almost no selectivity for Tyr
p
 over Ser
P
. The identification of 8VM1 and 8VP1 
Figure 5.9. Kinetics of 8VM1 and 8VP1 with their parent substrates, DNA-AAAYpAA and 
DNA-HEG-AAAYpAA, respectively. In addition, the catalytic properties of both these 
deoxyribozyme were assessed with their respective non-phosphorylated peptide 
substrates. The kobs value for 8VM1 with DNA-Tyr
P
 substrate was 0.49 h
–1
 and for 8VP1 
with DNA-HEG-Tyr
P
 substrate was 0.19 h
–1
.
  
Both these deoxyribozymes show at least 
200-fold selectivity for phosphate group, calculated based on 0.1% yield in 50 h for DNA-
Tyr  and DNA-HEG-Tyr substrates. 
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suggests that it may be possible to identify DNA catalysts with variable selectivity for the 
amino acid bearing the phosphate group. Both kinds of deoxyribozymes, selective and 
non-selective, can potentially be used for different applications.  
The catalytic activity of 8VM1 as well as 8VP1 was also examined with free peptide 
substrates. Kinetic assays were performed for both 8VM1 and 8VP1 with six different 
substrates: DNA-AAAY
p
AA, DNA-HEG-AAAY
P
AA, free AAAY
P
AA peptide, DNA-
AAAS
p
AA, DNA-HEG-AAAS
P
AA and free AAAS
P
AA peptide. Whenever free peptide 
was used in the assays, a separate oligonucleotide that base-pairs with the left-hand 
Figure 5.10. Kinetics of 8VM1 and 8VP1 with Tyr
P
 and Ser
P
-containing substrates.  For 
8VM1 kinetic assays were performed with the parent substrate, DNA-AAAYpAA and its 
Ser
P
-containing analog, DNA-AAASpAA. Similarly, for 8VP1 these assays were 
performed with DNA-HEG-AAAYpAA and DNA-HEG-AAASpAA substrates. The kobs 
values for 8VM1 were 0.49 h
–1 
and 0.07 h
–1 
with DNA-Tyr
P
 and DNA-Ser
P
 substrates 
respectively. Thus, 8VM1 has 7-fold selectivity for Tyr
P
 over Ser
P
. On the contrary, 8VP1 
shows almost no selectivity for Tyr
p
 over Ser
P
. The kobs values for 8VP1 were 0.15 h
–1 
and 
0.16 h
–1
 with DNA-HEG-Tyr
P
 and DNA-HEG-Ser
P
 substrates respectively.  
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binding arm of the deoxyribozyme was also added. The final concentration of the free 
peptide used in these assays was 1 mM.  
The activity of 8VM1 is strongly influenced by the tether that attaches the peptide to 
the DNA anchor (Fig. 5.11). 8VM1 was identified from a selection involving DNA-
AAAY
P
AA substrate. When this substrate is replaced with DNA-HEG-AAAY
P
AA, the 
product yields decrease by 10-fold. Also, 8VM1 showed no activity with the free peptide 
substrate. These observations suggest that 8VM1 recognizes the functional groups 
present in the linker that connects the DNA anchor to the peptide. 
The 8VP1 deoxyribozyme is sensitive to the tether, although to a lesser extent than 
8VM1 (Fig. 5.12). In contrast to 8VM1, this deoxyribozyme shows some activity with 
the free peptide substrate (5% in 50 h). 8VP1 was identified from a selection that 
employed a substrate in which the peptide is connected to the DNA anchor with an 
Figure 5.11. Kinetics of 8VM1 with a) DNA-AAAYpAA, DNA-HEG-AAAYpAA and free 
peptide AAAYpAA.  b) DNA-AAASpAA, DNA-HEG-AAASpAA and free peptide AAASpAA. 
The activity of 8VM1 is highly sensitive to the tether that attaches the peptide to the DNA 
anchor with product yields dropping from around 50% with DNA-AAAYpAA substrate to 
around 5% for DNA-HEG-AAAYpAA. This enzyme is inactive with the free peptide 
substrate. Similar trend is observed with Ser
P
-containing substrates.   
 
a) b) 8VM1 deoxyribozyme 8VM1 deoxyribozyme 
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intervening HEG linker. Due to the linker, the peptide is structurally less constrained, and 
behaves similar to a free peptide substrate. Hence it is not surprising to note that 8VP1 
also shows some activity with the free peptide.  
We also examined if the nature of the tether that connects the peptide substrate to the 
DNA anchor influence the activity of 8VM1 and 8VP1. Different phosphorylated 
peptides with N-terminal cysteine were synthesized and conjugated to the 3′-thiol DNA. 
Kinetic assays were performed using these substrates (Fig. 5.13). 8VM1 is highly 
sensitive to the kind of tether that connects the peptide substrate to the DNA anchor (Fig. 
5.13b). In contrast, the catalytic activity of 8VP1 does not depend on the tether identity 
(Fig. 5.13c).   
a) b) 
Figure 5.12. Kinetics of 8VP1 with a) DNA-AAAYpAA, DNA-HEG-AAAYpAA and free 
peptide AAAYpAA. b) DNA-AAASpAA, DNA-HEG-AAASpAA and free peptide AAASpAA. 
The activity of 8VP1 is sensitive to the tether that attaches the peptide to the DNA 
anchor with product yields dropping from around 40% with DNA-HEG-AAAYpAA 
substrate to around 5% for DNA-AAAYpAA. 8VP1 deoxyribozyme shows 5% activity with 
the free peptide substrate in 50 h. A similar qualitative trend is observed with Ser
P
-
containing substrate. 
8VP1 deoxyribozyme 8VP1 deoxyribozyme 
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Figure 5.13. Effect of tether identify that connects the peptide substrate to the DNA 
anchor on activity of 8VM1 and 8VP1 deoxyribozymes. a) Structural differences between 
tethers used in these assays. b) Kinetics of 8VM1 with DNA-AAAYpAA, DNA-SS-
CAAYpAA, DNA-HEG-AAAYpAA and DNA-HEG-SS-CAAYpAA substrates. The activity of 
8VM1 deoxyribozyme is highly sensitive to the identity of linker. c) Kinetics of 8VP1 with 
DNA-AAAYpAA, DNA-SS-CAAYpAA, DNA-HEG-AAAYpAA and DNA-HEG-SS-CAAYpAA 
substrates. The activity of 8VP1 is not influenced by change in the linker.  
 
b) 8VM1 deoxyribozyme c) 8VP1 deoxyribozyme 
a) 
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5.2.4 Investigating the specificity of 8VP1 deoxyribozymes for various peptide 
sequences  
For any application of deoxyribozyme to covalently tag phosphopeptides, it is critical 
to know about their selectivity for peptide sequence. We thus synthesized a range of 
peptide sequences, where the amino acid flanking the Tyr
P
 was changed. The alanine on 
either the N-terminal or the C-terminal side of Tyr
P
 in the parent substrate was replaced 
by phenylalanine, glutamic acid or lysine. These peptide sequences were conjugated to 
the DNA anchor. Kinetic assays were performed using these substrates (Fig. 5.14). The 
8VP1 deoxyribozyme was found to accept all peptide sequences with similar catalytic 
efficiency. The sequence generality of the 8VP1 deoxyribozyme suggests that DNA 
catalysts can be employed to covalently tag phosphopeptides without any peptide 
Figure 5.14. Sequence generality for the phosphopeptides substrate. Kinetics of 8VP1 
with DNA-HEG-CAXYpZA, where amino acids flanking Tyr
p
 is changed to X or Z = Phe, 
Glu, Lys.  
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sequence bias. The 8VM1 deoxyribozyme was not examined with these peptide 
substrates because the substrates used in these assays contains a disulphide tether, with 
which 8VM1 is inactive.  
5.3 Summary and Future Directions 
We have shown for the first time that DNA can catalyze highly selective covalent 
modification of phosphorylated Tyr and Ser residues in phosphopeptides. Two new 
deoxyribozymes, 8VM1 and 8VP1 were identified that catalyze the covalent attachment 
of phosphopeptides to an RNA molecule. In downstream applications, this RNA 
molecule may be used to report upon the amount of phosphopeptides in a sample, e.g. by 
RT-PCR. We also showed that the 8VP1 deoxyribozyme catalyzes reactions with a wide 
range of phosphopeptide substrates that differ in their sequences. This suggests that 
deoxyribozymes can be used to enrich phosphopeptides without peptide sequence bias.  
However, these deoxyribozymes to do not function well with the free peptide 
substrate and require that the peptide be bound to a DNA anchor. To address this 
limitation, selection approaches that can employ free peptide substrates need to be 
developed.    
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Chapter 6: Toward Identification of Tyrosine and Serine Kinase 
Deoxyribozymes 
6.1 Introduction  
Kinases are naturally occurring protein-based enzymes that transfer the phosphate 
group from ATP to the side chains of amino acids. Kinases are widespread in the human 
proteome and play important roles in numerous cellular processes including cell growth, 
differentiation, metabolism and cell death.
1-5
 They are key components of several cellular 
signaling pathways.
6,7
   
Advances in the field of synthetic biology
8,9
 and the recent engineering of a synthetic 
cell
10
 has renewed interest in the discovery of new enzymes that can be incorporated into 
genetic circuits.
11
 As kinases play various important roles in eukaryotic cellular 
processes, development of RNA-based kinases that can be integrated into genomes would 
be beneficial for efforts to develop artificial biosystems. In the studies described in this 
chapter, we sought to investigate the ability of DNA, to catalyze phosphorylation of 
amino acid side chains. DNA and RNA are expected to have similar capabilities for 
catalysis. 
Deoxyribozymes that can phosphorylate side chains of amino acids may be utilized in 
synthesis of phosphopeptides, which are useful reagents to study protein phosphorylation 
and dephosphorylation.
12
 Existing chemical methods for phosphopeptide synthesis are 
lengthy and often require multi-step processing.
13
 Deoxyribozymes that have kinase 
activity may also be employed to artificially regulate cellular processes that are 
dependent on phosphorylation of amino acid side chains.  
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In addition to these deoxyribozymes, artificial enzymes that can catalyze 
phosphorylation of the 3′-hydroxyl of DNA and 2′-hydroxyl of an internal ribose sugar in 
RNA molecules could also be useful. Kinases that phosphorylate the 3′-terminus of DNA 
are not found in nature; 3′-phosphorylated DNA molecules are typically obtained by 
solid-phase synthesis methods. Deoxyribozymes that phosphorylate the 3′-terminus of 
DNA may be employed to label (phosphorylate) DNA molecules in a sequence-specific 
manner. For example, by using -32P-ATP or ATPS as a phosphate donor, DNA can be 
radiolabeled or thiophosphorylated sequence-specifically, in contrast to existing labeling 
methods that do not have sequence specificity. Such deoxyribozymes may have analytical 
applications in detection of specific DNA sequences.
14
  
2′-Phosphorylated RNA is an intermediate involved in splicing of pre-tRNA to 
mature tRNA in Saccharomyces cerevisiae.
15
 Splicing in these organisms occurs in three 
steps: i) excision of intron by an endonuclease, ii) ligation of exons by a ligase, resulting 
in tRNA bearing 2′-phosphate at the ligation junction, iii) dephosphorylation of this 
intermediate by a dephosphorylating enzyme. Deoxyribozymes with 2′-phosphorylating 
activity may be utilized to synthesize 2′-phosphorylated tRNA intermediates that can aid 
in investigating the splicing mechanism. 
In vitro selection experiments were designed to identify deoxyribozymes that catalyze 
phosphorylation reactions with three substrates (Fig. 6.1): i) 2′-hydroxyl of an internal 
nucleotide in RNA, ii) 3′ hydroxyl of DNA, and iii) phenolic hydroxyl of tyrosine.  
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Figure 6.2. Phosphorylation and thiophosphorylation of tyrosine. The latter is separable 
from nonphosphorylated tyrosine-containing substrate due to the presence of sulphur. 
 
6.1.1 Strategy for identification of kinase deoxyribozymes  
In all selection efforts described in this thesis, the selection product was substantially 
larger in mass compared to the starting substrate and thus could be separated on PAGE. 
However, the addition of a phosphate to the reacting substrate adds only 80 mass units. 
This small difference in mass between the product and substrate is not enough to allow 
their separation by PAGE. Hence we sought to identify deoxyribozymes that can catalyze 
thiophosphorylation, adding a thiophosphate group to the substrate (Fig. 6.2). The 
chemical properties of the thiophosphate group could then be exploited to separate the 
product from starting substrate.  
Figure 6.1. Seeking deoxyribozymes for phosphorylation of 2′-OH of an internal 
ribonucleotide in RNA, 3′-OH of DNA and phenolic OH of tyrosine. 
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Different methods that are selective for the thiol moiety have been employed to 
separate thiophosphorylated molecules. These include covalent tagging of the thiol group 
with iodoacetamide-containing molecules
16
 and also methods that involve non-covalent 
interaction of the thiol group with mercury salts.
17,18
   
In the present investigations, the thiophosphorylated product was captured by non-
covalent interaction with phenyl mercuric chloride embedded in a polyacrylamide gel. 
These gels were prepared by addition of 
(N-Acryloylamino)phenyl mercuric 
chloride (APM) (Fig. 6.3) to acrylamide 
solution before polymerization. Bilayered 
polyacrylamide gels were prepared in 
which only the lower layer contains APM. 
In these gels, the thiophosphorylated 
product is captured at the non-APM/APM 
interface (Fig 6.4). Others have used a 
Figure 6.3. a) Chemical structure of (N-Acryloylamino)phenyl mercuric chloride (APM). b) 
APM incorporated in polyacrylamide gel matrix.  
 
Figure 6.4. A typical bilayered APM-
containing gel. Only the lower portion of the 
gel contains APM.  5′-thiophosphorylated 
DNA (right lane) is trapped at the non-
APM/APM interface. Non-thiophosphorylated 
DNA passes through the interface (left lane). 
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similar strategy to identify ribozymes that catalyze nucleotide synthesis.
19
  
6.2 Results and Discussion  
6.2.1 Selection design for MG-MM selections  
Six different selections, designated MG-MM (Fig. 6.6), were performed to identify 
deoxyribozymes that can phosphorylate the 2′-hydroxyl of RNA, 3′-hydroxyl of DNA 
Figure 6.5. Selection design for MG-MM selections.  
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and, tyrosine hydroxyl, using either 5′-thiotriphosphate-RNA or GTPS as a phosphate 
donor.  
The architectural design of MG and MH selections is inspired by 7S11, and related 
deoxyribozymes that catalyze formation of 2′,5′-branched RNA in a three-helix junction 
(3HJ) architecture (Fig 6.6a).
20,21
 This architecture places the 2′-hydroxyl of the ribose at 
the intersection of 3HJ in close proximity to the phosphate donor, 5′-thiotriphosphate-
Figure 6.6. a) 3D architecture of 7S11 and related deoxyribozymes. These 
deoxyribozymes catalyze the nucleophilic attack of 2′-hydroxyl of adenosine on the -
phosphate of 5′-triphosphate-RNA. b) 3D representation of MG selection. c) 3D 
representation of MH selection.  For both MG and MH selections, deoxyribozymes are 
sought for attack of 2′-hydroxyl of adenosine on -phosphate of 5′-thiotriphosphate RNA.  
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RNA (Fig 6.6b) or GTPS (Fig 6.6c).  
A model tripeptide AYA was used as a substrate in the ML and MM selections. To 
enable the selection process, this peptide was covalently attached via its N-terminus to a 
DNA anchor (Fig. 6.7). The covalent attachment was achieved by conjugating the N-
terminal amine of the peptide with a 3′-dialdehyde-DNA by reductive amination. Details 
of this conjugation reaction are discussed in Chapter 2, Section 2.2.2.  
The substrates that bind to the 3′ binding arm of the deoxyribozyme pool are 
designated as L substrates (left hand substrates). The general selection procedure and the 
steps involved are described in Chapter 2. Briefly, at the outset of each round of the 
selection, the L substrate was ligated via its 5′-terminus to the 3′-end of the 
deoxyribozyme pool strand using T4 DNA ligase. The procedure for this ligation reaction 
involves using a DNA splint and is discussed in detail in Chapter 2, Section 2.1.2. This 
ligated deoxyribozyme pool was then incubated with 5′-thiotriphosphate-RNA or GTPS 
under the selection conditions. Any DNA sequence that successfully catalyzes the 
thiophosphorylation of the L substrate can be separated from a substantial excess of 
catalytically inactive DNA sequences by passing through a bilayered APM gel. DNA 
Figure 6.7. DNA-peptide conjugates used in ML and MM selection. The N-terminus of the 
peptide is conjugated to the 3′-terminus of DNA using reductive amination. 
 
 110 
with the thiophosphate group will be trapped at the non-APM/APM interface. During the 
key selection step of each round, the incubation conditions were 50 mM HEPES, pH 7.5, 
150 mM NaCl, 2 mM KCl, 20 mM MnCl2, and 40 mM MgCl2 at 37 °C for 2 h. Both 
Mn
2+
 and Mg
2+
 were included because both divalent metal ions are known to support 
various DNA-catalyzed reactions.
22,23
 
6.2.2 Progress of MG-MM selections  
We first observed activity in round 5 of the MH and MK selections. The MH 
selection was aimed at identification of deoxyribozymes that can catalyze 
phosphorylation of a 2′-hydroxyl in RNA, and the MK selection was designed for 
identification of deoxyribozymes that can phosphorylate the 3′-hydroxyl of DNA. Both 
MH and MK selections employed GTPS as phosphate donor. Fig. 6.8 shows the round 7 
selection gel. The activity in these two selections saturated to around 50% by round 9. 
Fig. 6.9 shows the progress of this selection. No activity was observed in any other 
selections (MG, MJ, ML and MM) through round 11, and they were terminated.  
Figure 6.8. Selection gel from round 7 of MG, MH and MK and round 5 of MJ, ML and MM 
selections. The thiophosphorylated selection product is trapped at the non-APM/APM 
interface. Activity is observed only in MH and MK selections. 
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Activity in MH and MK selections was also observed in trans, when the 
deoxyribozyme pool is not connected to the substrate (Fig. 6.10). Thus these DNA pools 
do not require the covalent connection with the substrate to support catalysis. 5′-32P-
radiolabeled L substrate was incubated with excess of deoxyribozyme pool and three 
phosphate donors: 5′-thiotriphosphate-RNA, GTPS or GTP in separate assays. Activity 
was observed only with GTPS. The product identity for MK selection was confirmed by 
obtaining the MALDI mass spectrum of the 10MK selection reaction (Fig. 6.11).  
Although activity was observed for MH and MK selections, analogous MG and MJ 
selections (where the electrophile differs) did not show activity. In fact, MG and MJ 
selections that employ 5′-thiotriphosphate-RNA electrophile were expected to have a 
better chance of showing activity because the thiotriphosphate electrophile is held close 
to the nucleophile due to the Watson-Crick base pairing between the RNA and the 
binding arm of the deoxyribozyme (Fig. 6.5).  
    
 Figure 6.9. Progress of MH and MK selections. 
 
Figure 6.9. Progress of MH and MK selections. 
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Figure 6.10. Assays in trans for round 10 MH and MK selections. The catalytic activity of 
these deoxyribozyme pools was examined with three different phosphate donors, 5′-
thiotriphosphate-RNA, GTPS and GTP. Both deoxyribozyme pools showed activity only 
with GTPS. Incubation conditions: 50 mM HEPES, pH 7.5, 150 mM NaCl, 2 mM KCl and 
20 mM MnCl2, and 40 mM MgCl2 at 37 °C for 20 h. Note that product bearing normal 
phosphate group migrates faster than the substrate, thus leading to a band lower than 
the starting substrate.  
 
Figure 6.11. MALDI-TOF mass spectrum obtained after 10MK selection reaction. The 
spectrum was obtained in negative mode. Peaks corresponding to the starting DNA 
substrate and the product are observed. The mass difference is due to the addition of 
thiophosphate moiety (96 mass units).  
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     This discrepancy led us to investigate the stability of the 5′-thiotriphosphate-RNA 
electrophile under selection conditions. MALDI mass spectra were obtained for the 5′-
thiotriphosphate-RNA before and after incubation under selection conditions (Fig 6.12). 
The incubation conditions were 50 mM HEPES, pH 7.5, 150 mM NaCl, 2 mM KCl, 20 
mM MnCl2, and 40 mM MgCl2 at 37 °C for 12 h. The 5′-thiotriphosphate-RNA was 
completely hydrolyzed to 5′-diphosphate-RNA.  
To further investigate whether this instability of 5′-thiotriphosphate-RNA is 
associated with the presence of the thiophosphate group, MALDI mass spectra were 
obtained for a closely related triphosphate-RNA sequence (Fig 6.13). Unlike 5′-
thiotriphosphate-RNA, incubation of 5′-triphosphate-RNA under the selection conditions 
Figure 6.12. MALDI-TOF mass spectrum obtained for 5′-thiotriphosphate-RNA. These 
spectrums were obtained before incubation (left) and after incubation of RNA under 
selection conditions (right). The conditions of incubation are mentioned in the main text. 
Peak corresponding to the full thiotriphosphate is not observed after incubation under 
selection conditions, this thiotriphosphate group is completely hydrolyzed to 
diphosphate. The mass difference between the thiotriphosphate and diphosphate is 96.   
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led to much lesser hydrolysis to 5′-diphosphate-RNA (a small peak corresponding to the 
hydrolyzed product was observed in MALDI mass spectra after incubation). Thus, the 
instability of 5′-thiotriphosphate-RNA appears to be due to the presence of sulphur on the 
-phosphate of the thiotriphosphate moiety. To the best of our knowledge, such instability 
of thiotriphosphates has never been reported earlier.  
Absence of activity in the MG, MJ and ML selection experiments is associated with 
the instability of the phosphate donor. 50 picomoles of 5′-thiotriphosphate-RNA was used 
in these three selection experiments. The concentration of electrophile was much higher 
(100 nanomoles of GTPS) in the successful MH and MK selections. The MM selection, 
although also performed under the same conditions as MH and MK, failed. This could 
Figure 6.13. MALDI-TOF mass spectrum obtained for 5′-triphosphate-RNA. These 
spectrums were obtained before incubation (left) and after incubation of RNA under 
selection conditions (right). The conditions of incubation are mentioned in the main text. 
Small amount of triphosphate group in RNA is hydrolyzed under selection conditions, 
indicating that the 5′-triphosphate-RNA is stable under selection conditions.   
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possibly be due to the lower reactivity of the tyrosine hydroxyl that may require higher 
concentrations of GTPS for activity. Although the success of the MH and MK selections 
was promising, the electrophile GTPS was unstable, and the MH and MK pool did not 
show activity with GTP, restricting further development of these deoxyribozymes. We 
thus developed a new selection strategy that eliminates the use of 5′-thiotriphosphate-
RNA as a phosphate donor.   
6.2.3 Identification of kinase deoxyribozymes using capture deoxyribozymes:   
XA-XF selections  
A new two-step selection approach was developed to identify kinase deoxyribozymes 
(Fig. 6.14). We retained PAGE shift as the physical basis of our selection experiments. 
To achieve this, we first developed deoxyribozymes that are capable of attaching an RNA 
molecule to phosphorylated tyrosine and serine (Tyr
P
 or Ser
P
) within a short peptide 
substrate, while discriminating against the unphosphorylated variant. The development of 
these deoxyribozymes is discussed in Chapter 5. These deoxyribozymes are called 
―capture deoxyribozymes‖, and the RNA molecule that is attached to the 
phosphopeptides is called the ―tagging RNA‖. 
The selection protocol involves two steps. In the first step, the substrate is incubated 
under selection conditions with a phosphate donor (GTP or 5′-triphosphate-RNA). In the 
second step, the RNA molecule is attached to a small fraction of the phosphorylated 
product formed in the first step, using a capture deoxyribozyme. The catalytic DNA 
sequences attached to the product thus become separable on PAGE due to the added mass 
of the RNA (Fig. 6.14). This approach has the advantage over thiophosphate-based 
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separation (used in MG-MM selections) that deoxyribozymes that catalyze 
phosphorylation rather than thiophosphorylation, are identified directly. 
Six different selections, designated XA-XF (Fig. 6.15), were performed. Serine- or 
tyrosine-containing hexapeptides were used as substrates in these selections. These 
hexapeptides were either connected directly or via an intervening hexa(ethylene glycol) 
(HEG) linker to the 3′-terminus of the DNA anchor. For structural details of these DNA-
peptide conjugates, refer to Chapter 5, Fig. 5.3. The phosphate donor used in these 
selections was either 5′-triphosphate-RNA or GTP.  
Figure 6.14. Development of a novel two-step selection approach for identification of 
kinase deoxyribozymes. Phosphorylated amino acids are attached to a tagging RNA 
using capture deoxyribozymes after the selection step.  
 
 117 
The selection protocol was the same as described in Section 6.2.1. During the key 
selection step of each round, the incubation conditions were 50 mM HEPES, pH 7.5, 150 
mM NaCl, 2 mM KCl, 20 mM MnCl2, and 40 mM MgCl2 at 37 °C for 12 h. After the 
selection step, the reaction mixture was passed through a column with 30 kDa mass 
cutoff. This was required to remove salts and GTP present in the reaction mixture. The 
recovered DNA was dissolved in water and incubated with the tagging RNA and capture 
Figure 6.15. Selection design for XA-XF selections. After the selection step, the small 
amount of phosphorylated product formed is attached to a tagging RNA strand by 
using capture deoxyribozymes. 
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deoxyribozyme. Any DNA sequence with a phosphorylated amino acid side chain is 
attached to the tagging RNA by the capture deoxyribozyme. In every round of selection a 
control reaction was performed. This control reaction was performed using a 
phosphorylated peptide substrate that mimics the selection product. A phosphopeptide, 
AAAY
p
AA was synthesized using a standard peptide synthesis procedure. This peptide 
was then conjugated to the DNA anchor by reductive amination, as discussed in Section 
6.2.1. This DNA anchor-peptide conjugate was ligated to the DNA pool using T4 DNA 
ligase and is employed as a substrate for the control reaction. 25-40% yield was observed 
for the control reaction in each round of selection.  
Activity was first observed in round 8 of the XB and XE selections, and reached 
~40% for all the selections except the XD selection, where no activity was observed. Fig. 
6.16 shows the round 10 selection gel.  
We assayed the uncloned pools from round 11 of these selections in intermolecular 
format (in trans), i.e. with the DNA pool not connected to the substrate. These assays 
were performed using the 5′-32P-radiolabelled left-hand (L) substrate (Fig. 6.17). The 
incubation conditions were 50 mM HEPES (pH 7.5), 150 mM NaCl, 2 mM KCl, 20 mM 
MnCl2 and 40 mM MgCl2 at 37 °C for 12 h. Each of the uncloned DNA pool was tested 
Figure 6.16. Selection gel for round 10 of XB, XC, XD, XE and XF selections. 
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with three different substrates—DNA-AAAYAA, DNA-HEG-AAAYAA, and DNA-
HEG-AAASAA.  The DNA pools tested in trans were inactive with no product bands 
observed. The absence of activity in trans is an indicator of the requirement of a covalent 
attachment of DNA to the substrate for catalysis. Such dependence is undesirable for 
wider application of such a deoxyribozyme. Hence, further development of techniques to 
eliminate such dependence would be required. 
6.3 Summary 
This chapter describes some of our efforts to identify deoxyribozymes that can 
catalyze phosphorylation of amino acid side chains. In our first effort, deoxyribozymes 
were sought for thiophosphorylation of three different substrates: the 2′-hydroxyl of an 
internal ribose in an RNA molecule, the 3′-hydroxyl of DNA, and tyrosine within a 
Figure 6.17. Assays in trans with 11XB, 11XC, 11XE and 11XF deoxyribozyme pools 
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peptide substrate. The selection approach involved trapping of thiophosphorylated 
product at the interface of non-APM/APM bilayered gels. Deoxyribozymes that 
thiophosphorylate the 3′-hydroxyl of DNA and the 2′-hydroxyl of RNA using excess of 
GTPS as a phosphate donor were identified from these selection efforts (MH and MK). 
However, selections with lower concentrations of the phosphate donor, 5′-
thiotriphosphate-RNA electrophile, and those with peptide substrates were unsuccessful. 
Later it was found that the 5′-thiotriphosphate group hydrolyzes under selection 
conditions. Such instability of thiotriphosphate has not been reported earlier. A new 
selection approach was developed that eliminated the use of thiotriphosphates. In this 
approach, capture deoxyribozymes that can attach an RNA molecule to phosphorylated 
peptides were employed to identify kinase deoxyribozymes. The activity observed in 
these selection experiments depends on the covalent connection between the substrate 
and the DNA pool.  
6.4 Methods 
6.4.1 Synthesis of (N-Acryloylamino)phenyl mercuric chloride (APM) 
APM was synthesized by reaction between (p-aminophenyl)mercuric acetate and 
acryloyl chloride and purified by recrystallization from dioxane.
18
 The procedure was 
adopted from reference 18. 0.35 g of (p-aminophenyl)mercuric acetate was added to 8 
mL of acetonitrile in a RB flask while stirring in an ice bath. To this 2 mL of 1.2 M 
NaHCO3 added. This resulted in a biphasic suspension, where a white mobile pellet is 
formed. The mobile pellet remained at the bottom of the vessel. Subsequently, a total of 
0.2 mL of acryloyl chloride was added in 10L aliquots over a period of 10 min with 
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vigorous stirring. A voluminous white precipitate was formed, and the reaction was left 
in an ice bath with stirring for 14 h. This resulted in two phases: a clear lower phase and 
an upper phase containing the white product. The upper phase was removed and 
centrifuged at 4 
o
C. The resulting pellet was washed with H20 and re-dissolved by 
warming to 50 
o
C in 8.5 mL of dioxane. This solution was filtered and the filtrate was 
collected. Note that filtration should be performed rapidly, when the solution is warm, 
otherwise crystals can form during filtration. Crystals formed while the filtrate was kept 
at room temperature for 4-5 h. The solid was washed with H2O, dried under vacuum and 
stored at 4 
o
C. The crude yield obtained for synthesis of APM was 26%. TLC of the 
crude on silica plates using dioxane-EtOAc-triethylamine, 4.5: 4.5: 1, as a mobile phase 
gave a single ultraviolet-absorbing spot with Rf value of 0.55.The solid APM was 
dissolved in formamide to prepare a 1 mg/mL stock solution. This stock solution was 
further used to prepare APM-containing polyacrylamide gels.  
Polyacrylamide gels containing APM as a covalently linked component (Fig. 6.3) 
were cast by addition of appropriate amount of 1 mg/mL solution of APM to a solution 
contain standard amounts of acrylamide, bis(acrylamide), urea and polymerization 
initiator, TEMED.  
6.4.2 Determination of amount of APM in polyacrylamide gel required for 
trapping thiophosphorylated DNA 
To monitor the migration of thiophosphorylated oligo-nucleotides on APM gels, 
polyacrylamide gels containing APM were prepared at two different concentrations, 20 
μg/mL and 60 μg/mL. 5′-Thiophosphorylated DNA was prepared using T4 PNK and 
ATPγS as a phosphate donor. These oligonucleotides were 3’-radiolabeled using terminal 
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transferase (TdT) and -32P-dCTP. The samples were loaded on biayered APM gels (Fig. 
6.18). APM gels containing 20 μg/mL of APM retarded the motion of thiophosphorylated 
oligonucleotides but do not completely inhibit their migration. However, gels containing 
60 μg/mL of APM completely inhibit the motion of thiophosphorylated oligonucleotides. 
Because the purity of APM cannot be examined by any other means, such as NMR due to 
problems with handling toxic mercury salts, there might be variation in the amount of 
APM stock required to completely inhibit the migration of thiophosphorylated 
oligonucleotides. Thus, it is recommended that similar optimization should be performed 
for each new batch of APM prepared. 
 
DNA     
60–mer 
DNA    
70–mer 
DNA    
60–mer 
DNA    
70–mer 
APM layer containing 
20 g/mL of APM 
APM layer containing 
60 g/mL of APM 
+Ps -Ps +Ps -Ps +Ps -Ps +Ps -Ps 
Fig. 6.18. Optimization for amount of APM required for trapping thiophosphorylated 
DNA at AMP/non-APM interface.  
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